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Abstract
We present molecular dynamics (MD) simulations of two protein targets for drug design:
Triosephosphate isomerase (TIM) and Methyl CpG binding protein 2 (MeCP2). First, we
studied three TIM proteins: TcTIM, TbTIM and a chimeric protein (Mut1). The first two are
homologous enzymes with high sequence similarity, albeit different biophysical parameters.
The chimeric protein has TbTIM’s sequence and 13 single point mutations, which are sufficient
to obtain TcTIM-like behaviour in reactivation experiments. We analyzed the residue
interaction networks observed in the all-atom MD simulations, as well as their electrostatic
interactions and the impact of simulation length on them. A conserved salt bridge between
catalytic residues Lys 14 and Glu 98 was observed in all three proteins, but key differences
were found in other interactions concerning the catalytic amino acids. Although TcTIM forms
less hydrogen bonds than TbTIM and Mut1, its hydrogen bond network spans almost the entire
protein, connecting the residues in both monomers. Some of these interactions appeared only
after the first microsecond of the simulation, and convergence in the number of hydrogen bonds
was only reached during the last of the 3 μs of the simulation. Second, we performed MD
simulations of the methyl DNA binding domain (MBD), which is the only domain in MeCP2
with an available structure. After characterizing its structure both in solution and in the
presence of a surface in order to compare with high-speed atomic force microscopy
experiments (HS-AFM), we built the rest of the protein structure by ab initio modelling using
Modeller. This model was simulated in both all-atom and coarse-grained force fields. Two
main conformations were sampled in the coarse-grained simulations: a globular structure
similar to the one observed in the all-atom force field and a two-globule conformation. A
similar two-globule conformation has been observed in the HS-AFM experiments. Our results
are in good agreement with available experimental data. They predicted 4.1% of α-helical
content, the experimental result is 4%. Finally, we compared the model predicted by AlphaFold
to our Modeller model. Together, these simulations represent the first attempt to characterize
the structure and dynamics of the full-length MeCP2 protein.
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Summary for Lay Audience
We present molecular dynamics (MD) simulations of two proteins. The aim of an MD
simulation is to provide the time-evolution of a system by solving iteratively its equations of
motion. We first studied two Triosephosphate isomerase (TIM) proteins, one from
Trypanosoma cruzi (TcTIM), the parasite that causes Chagas’ disease, and one from
Trypanosoma brucei (TbTIM), causative agent of the African sleeping sickness, as well as a
chimeric protein with some characteristics of both of them. Our simulations allowed us to study
the electrostatic interactions between these proteins and explain why they behave differently
even though they are extremely similar. Next, we focused our study on the Methyl CpG binding
protein 2 (MeCP2). This protein is essential for growth and synaptic activity of neurons. Its
malfunction is associated to Rett syndrome, the most common cause of cognitive impairment
in females. This protein is an intrinsically disordered protein (IDP), a type of protein which
does not have a unique tertiary structure. IDPs are highly flexible and conventional methods
to study proteins are often not directly applicable to them. This is why the full-length structure
of MeCP2 has not been solved yet. The only available structure solely contains ~17% of its
amino acids, which represents the most ordered domain of this protein. We first performed MD
simulations on this structure, and then used ab initio modelling to complete the rest of the
protein. Since all-atom simulations of this model were not enough to guarantee adequate
sampling of its conformational space, coarse-grained modeling was used to complement the
atomistic picture. The coarse-grained simulations sampled a conformation that had not been
observed in the all-atom simulations but that was in good agreement with a conformation
previously observed in experimental data. Furthermore, our simulations predicted an α-helical
content of 4.1% (experimental value: 4%). Together, our simulations represent the first effort
to characterize the structure and dynamics of the full-length MeCP2 protein.
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1

Introduction

This thesis focuses on the study of a globular protein (triosephosphate isomerase) and an
intrinsically disordered protein (Methyl CpG binding protein 2). Molecular dynamics
simulations were used to characterize their structure and dynamics. In this chapter, a brief
introduction to proteins is made. Sections 1.4 and 1.5 briefly discuss the relevance of these
two proteins.

1.1 Proteins
Cells are rich in highly complex molecules termed macromolecules, and proteins are the
most abundant of them1. In fact, biochemical methods for protein detection suggest that
each human cell may express up to 15,000 distinct proteins2. They are functionally diverse
and involved in virtually all life processes in biological organisms, including the catalysis
of metabolic processes, energy transfer, gene expression, transport of solutes across
membranes, cellular communication, molecular recognition, defense mechanisms and
forming intracellular and extracellular structures1. Given the numerous roles of proteins,
the overall health of an organism depends on their normal function, and any significant loss
of it may lead to the development of a pathological process. Consequently, proteins
constitute ~80% of current pharmaceutical targets1.
Proteins have evolved to perform their function in a specific cellular environment. They
have therefore adapted to its biophysical characteristics, including temperature, pH,
salinity and pressure. Proteins denature at both high (typically ~60 °C) and low (typically
~-20°C) temperatures3, and their pH-optimum of activity corresponds to their pH-optimum
of stability4. The term “denaturation” refers to the phenomenon of loss of the threedimensional structure a protein has under physiological conditions, by either heat or
cooling (Figure 1.1)5. There is an ongoing debate between two opposing views that explain
cold denaturation: hydrophobic hydration and hydrophilic hydration. Each theory claims
that the dominant energetic contribution to cold denaturation comes from one of these two
types of residues, and the problem remains an open question in the scientific community3,6.
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Figure 1.1 Protein denaturation. The protein loses the three-dimensional structure it
has under physiological conditions. Green: stabilizing interactions, such as disulfide
bridges, hydrogen bonding and ionic bonds. Adapted with permission from Killian et
al7. Copyright 2021 American Chemical Society.
The structural organization of proteins is commonly described in terms of four different
aspects of covalent structure and folding patterns1. The levels of this hierarchy are known
as primary, secondary, tertiary and quaternary structure (Figure 1.2). The primary structure
is the ordered sequence of amino acids composing the protein chain. The secondary
structure refers to the initial folding of the sequence into helices and sheets. The overall
chain folds further into a three-dimensional compact tertiary structure, which constitutes
the third level of the hierarchy. All proteins have these three levels of structural hierarchy,
but there are some proteins that include more than one chain. In such cases, the spatial
arrangement of the different subunits constitutes its quaternary structure1.
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Figure 1.2 Structural hierarchy in proteins. The primary structure is the amino acid
sequence of the protein chain, the secondary structure is the initial folding of the chain
into helices and sheets and the tertiary structure is the three-dimensional structure of
the entire chain. If the protein includes more than one chain, the quaternary structure
constitutes the spatial arrangement of the different subunits. From Wikipedia, under
a CC BY 4.0 license8.
The amino acid chain is the primary and central component of the protein. It is formed by
linking amino acids via peptide bonds. A peptide bond forms when the carboxyl group of
one amino acid condenses with the amino group of another amino acid to eliminate water.
The succession of peptide bonds generates a backbone, from which the side chains are
projected. All amino acids have in common a central carbon atom (Cα) to which a hydrogen
atom, an amino group (NH2) and a carboxyl group (COOH) are attached. They are
distinguished by the side chain attached to the Cα through its fourth valence (Figure 1.3).
There are 21 amino acids specified by the genetic code but a few others occur in rare cases
by post-translational modifications. Of those, nine are termed “essential” amino acids since
humans and other vertebrates cannot synthesise them from metabolic intermediates9.
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Figure 1.3 Proteins are built by amino acids linked via a peptide bond, generating a backbone.
All amino acids have in common a central carbon atom (Cα) to which a hydrogen atom, an
amino group (NH2) and a carboxyl group (COOH) are attached. They are distinguished by
the side chain (Ri) attached to the Cα through its fourth valence. From Wikipedia, under a
CC BY-SA 3.0 license10.

Amino acids are divided into three different classes (plus some special cases) according to
the chemical nature of their side chain: hydrophobic, polar or charged (Figure 1.4). There
are two amino acids with acidic side chains: aspartic and glutamic acid. At neutral pH they
are fully ionized, containing a negatively charged carboxylate group (-COO-). Three amino
acids have basic side chains. Two of them are fully ionized and positively charged at neutral
pH: lysine and arginine. Histidine is only weakly basic and can be either positively charged
or neutral, depending on the ionic environment provided by the nearby residues in the
protein. Polar amino acids have zero net charge at neutral pH and contain at least one atom
with electron pairs available for hydrogen bonding to water. Hydrophobic amino acids have
a side chain that does not bind or give off protons. They do not participate in hydrogen or
ionic bonds and instead promote hydrophobic interactions11. Four amino acids are
considered to be special cases: 1) Cysteines can form a disulfide bond (-S-S-) when the
sulfhydryl group (-SH) in two of them becomes oxidized to form a covalent cross-link.
Disulfide bridges stabilize the folding of proteins, making them less susceptible to
degradation9. 2) Selenocysteine requires an elaborate synthetic and translational apparatus
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that does not resemble the canonical enzymatic system employed for the rest of the amino
acids12. Finally, 3) glycine and proline are both special but in opposite ways. Glycine
contains a single hydrogen as its side chain (Figure 1.4) and it therefore has a huge
conformational flexibility. In contrast, proline is geometrically limited due to the fusion of
its backbone and sidechain. This fusion prevents the N atom from participating in
hydrogen-bonding and also provides some steric hindrance to the α-helical conformation1.
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Figure 1.4 The genetic code specifies 21 amino acids which are divided into four groups
according to the chemical nature of their side chain. From Wikipedia, under a CC BY-SA 3.0
license13.
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The main driving force for the folding of globular proteins is the hydrophobic effect 14,15. It
plays an important role in the stability of biomolecules and is associated to cold
denaturation3. It is comprised by two energetic components: one enthalpic and one
entropic. The enthalpic hydrophobic effect is associated with the expulsion of disordered
water from hydrophobic regions. The entropic component is the result of an increase in
water disorder when hydrophobic surfaces aggregate and lessen the surface area around
which water molecules are more aligned16. The hydrophobic effect results in the burial of
the hydrophobic side chains in the core of the protein, creating a hydrophilic surface. The
hydrophobic core is densely packed and in the few cases where space remains, one or more
water molecules will hydrogen-bond to internal polar groups9. These are firmly bound and
can be regarded as integral parts of the protein structure. In order to bring the hydrophobic
side chains into the core, the main chain must also fold into the interior of the protein. It is,
however, highly polar, with one hydrogen bond donor (NH) and one acceptor (C’=O) for
each peptide unit. These polar groups are neutralized by the formation of hydrogen bonds,
giving rise to the secondary structure of proteins: α-helices and β-sheets (Figure 1.5)9.
The secondary structure provides a solid framework to the protein. It is relatively rigid and
is therefore the best-defined part of a protein structure when it is determined by both X-ray
and nuclear magnetic resonance (NMR) techniques.
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Figure 1.5 The most common secondary structures in proteins are the (A) α-helix and (B) βsheet. They are stabilized by the formation of hydrogen bonds between the side chains of the
amino acids that form them.

Motifs are combinations of secondary structure elements with a specific geometric
arrangement that are frequently found in protein structures. Some of them can be associated
with a specific function such as DNA binding, but others have no specific biological
function on their own. Several motifs combine into domains, which is the fundamental unit
of tertiary structure9. A domain can fold independently into a stable tertiary structure and
is structurally independent of the other domains. Polypeptide chains that are more than 200
amino acids long generally consist of two or more domains11. The process by which a
polypeptide chain acquires its correct three-dimensional structure and reaches the
biologically active native state is called protein folding9.

1.2

Protein structure and function

Initial efforts to crystallize proteins focused on hemoglobin, and although the first
photographs of hemoglobin crystals date from 1909, it took another 50 years before the
three-dimensional structure of this protein was solved17. At least 42 scientists have received
Nobel Prizes in Physics, Chemistry or Medicine for contributions that included the use of
X-rays or neutrons and crystallography. Recording X-ray diffraction images of
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macromolecular crystals turned out to be very challenging because of how easy they
deteriorate, they are sensitive to over-drying when exposed to air, and are temperature
sensitive17.
The thermodynamic hypothesis of protein folding, also known as “Anfinsen’s dogma”, is
a theoretic milestone. It states that the native structure of a protein represents a free energy
minimum determined by the totality of interatomic interactions and hence by the amino
acid sequence5. However, how the correct folding of a protein is selected from the
astronomically large number (1047 ) of possible conformations to give the native state in a
timescale of seconds or less, remained a paradox, known as Levinthal’s paradox, for a long
time18. It is now clear that folding pathways drive the protein efficiently towards a topology
close to that of the native state19. Moreover, proteins actually assume a large number of
nearly isoenergetic conformations and its motion can be discussed in terms of energy
landscapes, which describe the potential energy of the protein as a function of
conformational coordinates20.
For a long time, it was assumed that all proteins have a well-defined and stable threedimensional structure that is fully determined by the amino acid sequence. Early
experiments showed that proteins lost their function upon losing their structure and thus it
was believed that the native and functional state of a protein was necessarily a stable
structure. Results that ran counter this assumption were considered to be mistakes due to
either the experimental setup or the experimenter 21. As experimental evidence of
disordered proteins accumulated, it became impossible to ignore them, but they were often
considered as being functionally irrelevant. Many terms have been used to describe these
proteins, and it was not until 2005 that the field started to use consistent terminology and
the term “intrinsically disordered” became predominant 21.

1.3

Intrinsically disordered proteins

Intrinsically disordered proteins (IDPs) are a class of proteins that contain extensive
disorder, either local or global, that is important for function22,23. In contrast to globular
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proteins, IDPs do not have a well-defined secondary or tertiary structure and can adopt a
wide range of configurations (Figure 1.6). The structure-function paradigm, supported by
numerous reports of structures determined using X-ray crystallography and NMR
spectroscopy, slowed the acceptance of the biological role of highly dynamic and
disordered protein states. Additionally, the lack of common terminology precluded the
appearance of the idea that this class of proteins constitutes a separate and important
category of proteins21.
IDPs play a key role in signalling and regulatory functions, including the regulation of
transcription, translation and the cell cycle23. Their inherent flexibility enables them to
interact promiscuously with different targets on different occasions, they offer accessible
sites for post-translational modification and their extremely fast association rates allow
signals to rapidly turn on23. Studies have shown that about 10-35% of prokaryotic and 1545% of eukaryotic proteins contain disordered regions of at least 30 amino acids in
lenght24,25.

Figure 1.6 In contrast with globular proteins, IDPs lack a well-defined secondary or tertiary
structure. (A) A spinach thylakoid soluble phosphoprotein (PDBid: 2FFT), an IDP and (B)
human hemoglobin (PDBid: 1SI4), a globular protein.

The structural characterization of IDPs faces many challenges, they are extremely difficult
to prepare intact and often degrade during purification23, and since they do not have a single
well-defined structure, crystal-structure analysis can only indicate their presence through
the absence of electron density. Solution state NMR, residual dipolar couplings (RDCs),
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small angle X-ray scattering (SAXS) and paramagnetic relaxation enhancement (PRE) are
some of the tools that can provide detailed information on residual secondary structure,
transient long-range contacts and dynamics of disordered proteins, nevertheless, describing
their ensemble of conformations remains a challenge26,27.
One way to complement experimental studies is to use computer simulations and statistical
thermodynamics as tools for atomic-level characterizations and thermodynamic
descriptions. Since 1994 the Critical Assessment of Structure Prediction (CASP), a largescale community experiment, has ben held every two years28. CASP provides an avenue
for objective testing and assessment of protein structure modeling methods. In CASP14,
the neural network-based model AlphaFold29, demonstrated accuracy competitive with
experimental structures in a majority of cases. However, the regions with very low
confidence in the predictions overlap with intrinsically disordered regions30.
Achieving an accurate characterization of IDPs via simulations is also challenging, because
they rely on the accuracy of the force field. Protein force fields were developed to target
globular proteins and their applicability to IDPs is not straightforward 31. In fact, studies
have shown that prediction of native-state structures and folding rates appear to be more
robust than the detailed kinetics and the properties of unfolded states, which share some
characteristics with disordered proteins32–34. A community-based blind test based on
CASP, the Critical Assessment of protein Intrinsic Disorder prediction (CAID) experiment,
was established in 2020. With the objective to determine the state-of-the-art in prediction
of intrinsically disordered regions, the experiment evaluated 43 methods on a dataset of
646 proteins from DisProt 35. Interestingly, the best methods used deep learning techniques
and notably outperformed physicochemical methods36.
Force fields have two major shortcomings in describing IDP structures. The first one is that
they present variations in their structural propensities, as force fields tend to overpopulate
either α-helical or β-sheet structures34,37. This problem has been addressed via explicit
optimization of backbone torsion parameters against NMR data38. These improvements can
be found in the latest published force fields, including CHARMM22* 32, CHARMM3639,
Amber ff03*40 and Amber ff99SB*-ILDNP41 amongst others. The second problem is the
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prediction of structures that are too compact. This issue has been addressed by either
strengthening protein-water interactions (Amber ff03ws force field42), or by using a water
model with an increased Lennard-Jones well-depth (TIP4P-D water model43). In spite of
these advances, studies that compare different force fields for protein folding and to sample
the structural ensembles of IDPs have found large differences across force fields32,34,44,45.
Although the accuracy of force fields for IDP simulations is not well-characterized,
improving the existing force fields is an ongoing effort in the scientific community46–48.
IDPs have relatively flat energy landscapes and consequently, extensive simulations are
needed to ensure that the conformational space has been adequately sampled.

1.4

Triosephosphate isomerase - TIM

The protein described in this section was studied in this work.
Triosephosphate isomerase (TIM) is an enzyme that catalyzes the interconversion of
dihydroxyacetone phosphate (DHAP) into D-glyceraldehyde 3-phosphate (GAP), an
essential step in the glycolytic pathway49. TIM is considered a “perfect” catalyst because
the rate of the overall reaction is diffusion controlled50. Its first crystal structure revealed
for the first time the TIM barrel topology, an eightfold repeat of (βα) units in such a way
that β-strands in the inside are surrounded by α-helices on the outside (Figure 1.7)51. This
is now one of the most common structural motifs in proteins, it is present in ~10% of all
known proteins and is the most common enzyme fold in the Protein Data Bank (PDB)
database51–53.
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Figure 1.7 The TIM barrel is an eightfold repeat of (βα) units in such a way that β-strands in
the inside are surrounded by α-helices on the outside. Schematic view of the TIM barrel from
(A) the top and (B) its side. Colored by region.

The four catalytic residues are strictly conserved throughout the TIM family52. They are
located in three of the eight βα-loops, being loop 1 (N11, K13), loop 3 (H95) and loop 6
(E167)51. This last loop is highly flexible and it moves from open to close, sampling
multiple conformational states54. TIM is completely active only in the dimeric form, even
though the catalytic residues of each active site are provided by the same subunit. Regions
1, 4 and 8 become more rigid when the dimer is formed, which in turn rigidifies the two
separate active sites, providing full catalytic power 51,55.
TIM activity is of critical importance for the proper functioning of cells and it is essential
for maintaining life under anaerobic conditions. Consequently, it has been used as a target
for drug design when dealing with human parasites56–58. In particular, the TIM proteins of
Trypanosoma cruzi (TcTIM), the parasite that causes Chagas’ disease, and Trypanosoma
brucei (TbTIM), causative agent of the African sleeping sickness, have been the object of
many studies59–62. These two homologous enzymes have high similarity yet significant
differences in their biophysical parameters. A study by Bolaños et al.63 showed that it is
sufficient to mutate 13 amino acids on TbTIM to obtain TcTIM-like behaviour in
reactivation experiments. Circular dichroism indicated that the chimeric proteins had a
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TIM fold, however, the role that these mutations have on the structure and dynamics of the
proteins is not well understood.

1.5

Methyl CpG binding protein 2 - MeCP2

The protein described in this section was studied in this work.
Methyl CpG binding protein 2 (MeCP2) is a transcriptional regulator essential for growth
and synaptic activity of neurons64. The malfunction of this protein is associated to the Rett
syndrome, one of the most common causes of mental retardation in females 65,66. This Xlinked neurologic disorder often causes death in infancy or severe neonatal encephalopathy
in males67.
MeCP2 is composed of six different domains: the N-terminal domain (NTD), the methylCpG binding domain (MBD), the intervening domain (ID), the transcriptional repression
domain (TRD) and the C-terminal domain (CTD), which is subdivided into CTD-α and
CTD-β68. MeCP2 is an IDP and its physical characteristics make its structural
characterization a challenge. Out of the six domains, only the MBD domain has structural
information available, and it only accounts for ~17% of the 486 amino acids in the protein
(Figure 1.8)69.

Figure 1.8 Three-dimensional structure of the MBD domain, the only ordered domain in
MeCP2 and with a known structure. PDBid: 1QK969. Colored by secondary structure: αhelix (pink), β-sheet (cyan) and random coil (green).

15

Circular dichroism (CD) of recombinant human MeCP2 showed that the protein consists
of ~35% β-strand/turn, 5% α-helix and almost 60% is unstructured70. Further CD studies
of isolated NTD, ID, TRD and CTD domains confirmed their lack of stable secondary
structure71. Additionally, it was experimentally demonstrated that the NTD, CTD and TRD
domains can undergo a coil to helix transition, with the TRD showing the greatest tendency
for helix formation71.
Due to the lack of a three-dimensional structure of the full-length protein, only two
computational studies have been reported, and they both focus on the MBD domain72,73. A
better understanding of the tertiary structure of MeCP2 is needed in order to discern the
molecular links between MeCP2 domain organization, the multifunctionality of the
protein, and the cellular pathogenesis of the Rett syndrome.
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2

Molecular dynamics simulations

In this work, molecular dynamics simulations were used to study two different proteins.
The following chapter gives an overview of this method.

2.1 Introduction
The field of molecular dynamics (MD) simulations began with the work of Alder and
Wainwright on hard-sphere liquids in the late 1950’s1, followed in 1964 by Rahman’s work
on a MD simulation of liquid argon with a Lennard-Jones potential2. Stillinger and
Rahman’s study of liquid water3, published in 1971, finished preparing the stage, and in
1975 the first simulation of a macromolecule of biological interest was published 4. The
simulation concerned BPTI, a small, highly stable protein, whose X-ray structure became
available the same year5. Although this simulation was done in vacuum with a crude
molecular mechanics potential and lasted for only 9.2 ps, the results were essential in
changing our view of proteins as relatively rigid structures. This work is part of what led
to the Nobel Prize in Chemistry to Karplus, Warshel and Levitt in 2013. As a result of
methodology improvements as well as the ever increasing computing power, MD
simulations have become a standard tool in the study of biomolecules6.
An MD simulation produces a dynamical trajectory for a system composed of N atoms by
integrating Newton’s equations of motion. A set of initial conditions, a model to represent
the forces acting between atoms, and boundary conditions are needed. The most common
choice is periodic boundary conditions (PBC). Then, one needs to solve the classical
equations of motion:
𝑚𝑖 𝒓̈ 𝑖 = 𝒇𝑖 = ∑𝑁𝑗=1 𝒇𝑖𝑗
(𝑗≠𝑖)

𝜕

𝒇𝑖 = − 𝜕𝒓 𝑢(𝒓),

(1)

𝑖

where 𝑚 is the mass of atom 𝑖, 𝒓̈ 𝑖 is its acceleration, and the sum is over all 𝑁 atoms,
excluding 𝑖 itself. We need to calculate the forces 𝒇𝑖 acting on each atom, which are in turn
derived from a potential energy 𝑢 = 𝑢(𝒓) where 𝒓 = (𝒓1 , 𝒓2 , … , 𝒓𝑁 ) represents the
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complete set of 3𝑁 atomic coordinates. Newton’s third law implies that the force exerted
by the atom 𝑗 on atom 𝑖 is 𝒇𝑖𝑗 = −𝒇𝑗𝑖 , so each atom pair needs to be examined only once.
The potential energy function can be written as
(2)

𝑎𝑛𝑔𝑙𝑒
𝑢 (𝒓) = ∑ 𝑘𝑖𝑏𝑜𝑛𝑑 (𝑏𝑖 − 𝑏0 )2 + ∑ 𝑘𝑖
(𝜃𝑖 − 𝜃0 )2
𝑏𝑜𝑛𝑑𝑠

𝑎𝑛𝑔𝑙𝑒𝑠

∑

+

𝑘𝑖𝑑𝑖ℎ𝑒 [1 + 𝑐𝑜𝑠(𝑛𝑖 𝜑𝑖 − 𝜑0 )] +

𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠
12

𝑗≠𝑖

𝑘𝑖𝑖𝑚𝑝 (𝜓𝑖 − 𝜓0 )2

𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟𝑠

𝜎𝑖𝑗
+ ∑ ∑ 4𝜀𝑖𝑗 [( )
𝑟𝑖𝑗
𝑖

∑

6

𝜎𝑖𝑗
𝑞𝑖 𝑞𝑗
− ( ) ] + ∑∑
.
𝑟𝑖𝑗
𝑟𝑖𝑗
𝑖

𝑗≠𝑖

The exact form of Equation 2 is determined by the force field, which contains all the
necessary strength parameters 𝑘𝑖 and constants therein (𝑏0 , 𝜃0 , 𝜑0 , ψ0 , etc). Charges are
usually determined by quantum chemical calculations by fitting partial atomic charges to
the quantum electrostatic potential, while force constants and idealized bond lengths and
angles are often taken from crystal structures and adapted to match normal mode
frequencies for certain peptide fragments7. All common force fields group these terms into
bonded (first four terms) and non-bonded (last two terms) interactions. These are illustrated
in Figure 2.17–9.

Figure 2.1 Schematic view of force field interactions. Covalent bonds are indicated by heavy
solid lines and nonbonded interactions by a light, dashed line. A) Atoms 1 and 2 represent the
bond length, atoms 2, 3 and 4 the angle θ, and atoms 4 and 5 show a nonbonded interaction
with a distance 𝒓𝒊𝒋 . B) Atoms 1 and 4 represent the dihedral angle 𝝋 around the central bond
between atoms 2 and 3. This dihedral represents the angle at which two adjacent planes meet.
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In Equation 2, the first term represents the oscillations about the equilibrium bond length
𝑏0 . It is represented with a harmonic potential where 𝑘𝑖𝑏𝑜𝑛𝑑 represents the force constant
of the bond. This constant is generally very high, indicating that it takes a large amount of
energy to stretch or compress a chemical bond. The harmonic potential is a good
approximation for small deviations (smaller than 10%) from the reference bond length.
Additionally, the use of the harmonic function implies that the bond cannot be broken, so
no chemical processes can be studied. Since large deviations from the reference bond
length are rare in simulations of biological macromolecules, other potential energy
functions are rarely used8.
The second term in Equation 2 represents the oscillations of three atoms about an
𝑎𝑛𝑔𝑙𝑒

equilibrium bond angle 𝜃0 . The value of the force constants 𝑘𝑖

is typically lower than

those for bond stretching, indicating that it takes less energy to deviate a bond angle from
its reference value9.
The third term is the dihedral term (also known as the torsional term) and it represents the
torsional rotation of four atoms around a central bond. Torsional motions are typically
hundreds of times less stiff than bond stretching motions. They play a crucial role in
determining the local structure of a macromolecule and the relative stability of different
molecular conformations. In the potential energy function
𝑢(𝜑𝑖 ) =

[1 + 𝑐𝑜𝑠(𝑛𝑖 𝜑𝑖 − 𝜑0 )]
∑ 𝑘𝑑𝑖ℎ𝑒
𝑖

(3)

𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠

𝑘𝑖𝑑𝑖ℎ𝑒 determines the height of the potential energy barrier, 𝑛𝑖 the number of minima
between 0 and 2π, and φ0 is the phase factor which determines their position. There is no
unique way to determine the balance between the torsional, and the van der Waals and
Coulomb components in the potential energy profile observed upon rotation of a dihedral
angle. It is common practice between force field developers to combine Equation 3 with
non-bonded energy terms to produce the desired torsion profile9.
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𝑖𝑚𝑝
The term ∑𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟𝑠 𝑘𝑖 (Ψ𝑖 − Ψ0 )2 is introduced in order to preserve the planarity of

groups with flat geometry, such as sp2 hybridized carbons in carbonyl groups or in aromatic
rings. It provides a penalty function for bending out-of-plane8.
The fifth term in Eq. 2 represents the van der Waals component of the potential and is also
known as the Lennard-Jones 12-6 potential. Here, 𝜀𝑖𝑗 represents the depth of the well, and
𝜎𝑖𝑗 the distance at which the potential energy between atoms 𝑖 and 𝑗 becomes zero. It is

possible to define a set of parameters (𝜀𝑖𝑗 and 𝜎𝑖𝑗 ) for each different pair of atoms, but for
convenience, most force fields give individual atomic parameters (𝜀𝑖 and 𝜎𝑖 ) together with
rules on how to combine them (see section 2.5). The Lennard-Jones potential has an
attractive and a repulsive term. The attractive one originates from the dispersion forces
generated by instantaneous dipoles, which arise from fluctuations in the electronic charge
distributions of all atoms. The repulsive term is due to the Pauli exclusion principle 9.
The molecular electronic density can be obtained with high accuracy by means of highlevel quantum mechanics calculations, however, reducing such density to a manageable
description to be used in MD simulations is not trivial. The usual choice is to assign a
partial atomic charge to each nucleus. This is a convenient representation as it allows the
use of Coulomb’s law to compute their contribution to the total energy,
𝑢 (𝒓) = ∑ ∑
𝑖

𝑗≠𝑖

𝑞𝑖 𝑞𝑗
,
𝑟𝑖𝑗

(4)

where 𝑟𝑖𝑗 is the distance between nuclei 𝑖 and nuclei 𝑗, and 𝑞𝑖 and 𝑞𝑗 are the partial atomic
charges. The most common way to calculate them consists in performing an ab initio
calculation and then derive them from the quantum mechanical potential. Unfortunately,
they cannot be derived unambiguously because atomic charges are not experimental
observables and the methods developed to determine them do not always produce the same
distribution of partial charges8.
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2.2

Integration algorithms

Having computed all forces between the particles, one can integrate Newton’s equations
of motion. There are many methods to perform step-by-step numerical integration of these
equations, but many of them are too costly or not stable enough for long simulations 10.
There are several requirements for a good integrator. The speed of the algorithm is relevant
but not crucial because the fraction of time spent integrating the equations of motion,
compared to computing the interactions, is relatively small. Accuracy for large time steps
is more important, because the longer the time step one can use, the fewer evaluations of
the forces are needed per unit of simulation time. Algorithms that use large time steps
achieve this by storing information in increasingly higher-order derivatives of the particle
coordinates and consequently, they require more memory storage. Another important
criterion is energy conservation, which can occur short-term and long-term. The
sophisticated higher-order algorithms have very good energy conservation for short times
(i.e., during a small number of time steps). However, they often have energy drifts for long
times. In contrast, Verlet-style algorithms tend to have only moderate short-term energy
conservation but little long-term drift11.
Newton’s equations of motion are time reversible but many algorithms are not. As a
consequence, if one were to reverse the momenta of all particles at a given instant, the
system would not trace back its trajectory even if the calculation was done with infinite
numerical precision. Many seemingly reasonable algorithms differ in another crucial
aspect from Hamilton’s equation of motion. True Hamiltonian dynamics leave the
magnitude of any volume element in phase space unchanged (a property known as
symplecticity), but many numerical schemes, in particular those that are not timereversible, do not preserve the area in phase space. This in turn is not compatible with
energy preservation and thus non-area-preserving algorithms will have serious long-term
energy drift problems11.
The Verlet algorithm12 is fast, requires very little memory, has a fair short-term energy
conservation and exhibits little long-term energy drift. This is due to the fact that this
algorithm is time reversible and area preserving. Its disadvantage is that it is not particularly
accurate for long time steps and so one needs to compute the forces on all particles rather
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frequently. To derive it, we start with a Taylor expansion of the coordinate of a particle
around time 𝑡,
𝑟(𝑡 + ∆𝑡) = 𝑟(𝑡) + 𝑣(𝑡)∆𝑡 +

𝑓(𝑡)
2𝑚

∆𝑡 2 +

∆𝑡 3
3!

𝑟⃛ + 𝑂(∆𝑡 4 )

(5)

similarly,
𝑟(𝑡 − ∆𝑡) = 𝑟(𝑡) − 𝑣 (𝑡)∆𝑡 +

𝑓 (𝑡) 2 ∆𝑡 3
∆𝑡 −
𝑟⃛ + 𝑂(∆𝑡 4 )
2𝑚
3!

(6)

Adding these two equations we get:
𝑟(𝑡 + ∆𝑡) + 𝑟(𝑡 − ∆𝑡) = 2𝑟(𝑡) +

𝑓(𝑡) 2
∆𝑡 + 𝑂(∆𝑡 4 )
𝑚

(7)

𝑓(𝑡) 2
∆𝑡
𝑚

(8)

which gives
𝑟(𝑡 + ∆𝑡) ≈ 2𝑟(𝑡) − 𝑟(𝑡 − ∆𝑡) +

The estimate of the new position has an error that is of the order of ∆𝑡 4 , where ∆𝑡 is the
time step used in the simulation. The Verlet algorithm does not use the velocity to compute
the new position. However, one can derive the velocity from knowledge of the trajectory
using:
𝑟(𝑡 + ∆𝑡) − 𝑟(𝑡 − ∆𝑡) = 2𝑣 (𝑡)∆𝑡 + 𝑂(∆𝑡 3 )

(9)

which then gives,
𝑣 (𝑡 ) =

𝑟(𝑡+∆𝑡)−𝑟(𝑡−∆𝑡)
2∆𝑡

+ 𝑂(∆𝑡 2 ).

(10)

The expression for the velocity is only accurate to order ∆𝑡 2 . Having the new positions,
those at time 𝑡 − ∆𝑡 may be discarded. The current positions become the old ones and the
new positions become the current ones11.
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The Verlet algorithm as defined above is hardly ever used in practise. Instead, the velocityVerlet algorithm is employed. It has the same properties as the Verlet algorithm but evolves
explicitly the velocities with an accuracy in the order of 𝑂(∆𝑡 4 ). In this algorithm, the new
positions are calculated from
𝑟(𝑡 + ∆𝑡) = 𝑟(𝑡) + 𝑣 (𝑡)∆𝑡 +

𝑓(𝑡) 2
∆𝑡
2𝑚

(11)

and the velocity is updated by:
𝑣 (𝑡 + ∆𝑡) = 𝑣(𝑡) +

𝑓(𝑡+∆t)+𝑓(𝑡)
2𝑚

∆t.

(12)

Note that in this algorithm, we can compute the new velocities only after we have computed
the new positions, and from these, the new forces.
There are still ongoing efforts to develop new algorithms that allow the use of longer time
steps while preserving the dynamics. In particular, several multiple step algorithms have
been proposed in recent years13–15. These algorithms exploit the time scale separation
between faster (which can be integrated more frequently) and slower (updated at a lower
rate) degrees of freedom.

2.3

Thermostats and Barostats

Integration of Newton’s equations of motion produces the microcanonical ensemble. In
this ensemble the number of particles N, the volume V and the total energy E are constant
(NVE ensemble). Experiments, however, are typically conducted at constant temperature
and/or constant pressure and, therefore, it is desirable to perform MD simulations in
ensembles such as the canonical (NVT) or the isothermal-isobaric ensemble (NPT). This
can be achieved with the use of thermostats and barostats9.
Thermostats can be roughly divided into global and local. Global ones act instantaneously
with the same strength on all particles of the system. Local thermostats, on the other hand,
act on individual atoms or pairs and dissipate energy on a spatially localized scale.

33

Nevertheless, the addition of one may significantly affect the thermal fluctuations in the
system and cause energy drifts that sometimes have their origin in the accumulation of
numerical errors16.
One of the best known artifacts in MD simulations is the so-called “flying ice cube”17. Over
the simulation time there is a gradual loss of the vibrational, internal kinetic energy and an
increase in translational external kinetic energy. Eventually the system freezes and
becomes a flying ice cube. This artifact is a violation of the equipartition principle and is
due to velocity rescaling, a technique applied by global thermostats including the
commonly used Berendsen weak-coupling method18 and Nosé-Hoover19,20. This problem
can be solved in three different ways. The first one is velocity reassignment instead of
rescaling. This essentially means using a local thermostat such as the Andersen21,
Langevin22,23 or the DPD methods24,25. The second way of addressing this problem is to
remove the motion of the center of mass and the third one is to use better algorithms for
rescaling. Modern simulation protocols remove the center of mass motion periodically
throughout the simulation and use sufficiently large coupling times for global thermostats.
The velocity rescale algorithm of Bussi, Donadio and Parrinello 26,27 is a modification of
the Berendsen weak coupling method, has been shown to perform well and is widely
popular16.
Simulations using the NPT ensemble are typically needed for membrane systems. This
ensemble is achieved through the use of a barostat. The most popular ones include the
Langevin piston28, the Parrinello-Rahman method29, the Martyna-Tuckerman-TobiasKlein algorithm30,31 and the Berendsen barostat18. The Berendsen method is conceptually
simple and is very commonly used but is not entirely correct since it does not produce the
correct canonical distribution32. In contrast, the Parrinello-Rahman barostat produces the
correct distribution, but is computationally more expensive16.
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2.4

Force fields

A force field is a mathematical expression of the potential energy of a system of particles.
It consists of an analytical form of the interatomic potential energy (Equation 2) and its set
of parameters. The fundamental assumption is the Born-Oppenheimer approximation33,
which neglects the motion of atomic nuclei when describing the electrons in a molecule.
The physical basis of this approximation is that the electrons and the nucleons have more
than a 1000-fold mass difference, which in turn causes the nuclei to move ~1000 times
more slowly than electrons. The Born-Oppenheimer approximation makes possible to
separate the motion of the nuclei and the electrons, and therefore to write the system as a
function of the nuclear coordinates only and thus enables the use of classical mechanics.
There are two other assumptions at work: additivity and transferability. Additivity means
that the potential energy of any system can be written as a sum of potentials with a simple
physical interpretation (bond stretching, angle bending, van der Waals interactions, etc.).
Additive force fields are characterized by point charges in each of the atoms, centered on
the atomic nucleus. Many popular atomistic force fields are additive, the most widely used
are AMBER34,35, CHARMM36,37, GROMOS38,39 and OPLS40. Additive force fields are
generally parametrized using a mean-field approximation such that the electronic
distribution of molecules cannot change their response to variations in the local electric
field. Polarizable force fields have three primary methods to treat polarization classically
via the induced point dipole, fluctuating charge and the Drude oscillator. The requirement
to solve the magnitude of all the induced dipoles self-consistently is computationally
demanding, and it is typically the limiting factor in the efficiency of all polarizable
models41. The inclusion of explicit electronic polarization allows one to transfer gas-phase
ab initio potentials to condensed phases, and is recommended in cases where permanent
polarization does not account for most of the simulated effect, such as in evaluating the
redox potential of proteins and to study proton transport in membrane channels 42. Recent
efforts in developing new polarizable force fields have been made to improve water 43,
RNA44 and urea crystals and aqueous solutions45 simulations.
The term transferable means that the force field parameters derived from a small set of
molecules can be applied to molecules with similar chemical structures, and that the force
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field is transferable to different state points (e.g., pressure, temperature) and to different
properties (e.g., thermodynamic, structural) 9,46. While a force field that uses special types
of interactions for specific molecules may be very accurate for a particular application, it
could be considered not transferable and would therefore have very limited predictive
power for unrelated applications. There are two types of parameter transfers. The first one
is internal, in which the force field parameters are transferred within a molecule, such as
using the parameter derived for a residue, in a protein. This type of transfer is valid in most
cases. The other one is external, parameters derived from a molecule are used in a similar
but different molecule. For example, parameters derived for alkanes may be used for
halogen-substituted alkanes. External transfers can introduce considerable errors simply
because some of the molecular properties may not be strictly transferable 47.
Beyond the three main assumptions made by force fields, they can differ in the way they
treat the interactions between particles. There are two main differences in the bonded
contributions of the force fields. The first one is the use of “improper” dihedrals, which can
be used to maintain chirality or planarity at an atom center with bonds to three other atoms.
While AMBER34,35 and OPLS40 apply the dihedral term in Equation 2 to planar groups,
CHARMM36,37 adds a separate term for improper dihedral energy that has a quadratic
dependence on the value of the improper dihedral. The second difference is that the
CHARMM36,37 force field adds an Urey-Bradly angle term. This term treats the two
terminal atoms in an angle with a quadratic term that depends on the distance between the
atoms48.
Similar to the bonded terms, there are two key differences between force fields in the
treatment of non-bonded interactions. The first one lies in the combination rules for the
determination of the Lennard-Jones parameters 𝜀𝑖𝑗 and 𝜎 𝑖𝑗 between dissimilar atoms. The
subscript ij associated with these parameters is used to make explicit their dependence on
the atom types for both atom i and atom j. OPLS40 uses the geometric mean to calculate 𝜀𝑖𝑗
1/2

and 𝜎 𝑖𝑗 , i.e. 𝑘𝑖𝑗 = (𝑘𝑖 𝑘𝑗 )

, whereas AMBER34,35 and CHARMM36,37 use the geometric
1

mean for 𝜀𝑖𝑗 and the arithmetic mean, 2 (𝜎𝑖 + 𝜎𝑗 ), for 𝜎 𝑖𝑗 , also known as the LorentzBerthelot rules of mixing49. The Lorentz-Berthelot rules work reasonably well in most
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cases but there are some instances in which they fail in a rather striking manner, see for
example the discussion in Refs. (16) and (50). For example, they may lead to incorrect
thermodynamic properties for simple binary mixtures and they give surface-gas
interactions that are 10 times stronger than they should be16. The second difference is the
handling of 1,4 non-bonded interactions. These are the interactions between atoms 1 and 4
in the 1-2-3-4 dihedral. Amber scales 1,4 Lennard-Jones interactions by ½ and Coulomb
interactions by 1⁄1.2, OPLS40 applies a factor of ½ to both interactions, and CHARMM36,37
does not scale them except for a few atom type pairs48.
The lack of consensus on the best way to treat both bonded and non-bonded interactions
suggests that there is no single best solution to this problem. Both OPLS 40 and AMBER34,35
have undergone revisions of their Φ and Ψ dihedral parameters, giving rise to a number of
descendants from their original force field40,51. CHARMM36,37 has followed a different
approach, by adding a new “correction map” (CMAP) term to the potential energy
equation48. This term is a grid-based correction for the Φ-, Ψ-angular dependence of the
energy37.

2.5

Time scales

In MD simulations one would ideally like to choose a time step as large as possible, in
order to sample phase space rapidly and save on computer expense. However, if a too large
time step is chosen, the motion of particles becomes unstable due to the truncation error in
the integration process and the total energy of the system may increase rapidly with time.
This behavior is called exploding and is caused when a large time step propagates the
positions of atoms to be partially overlapping, creating a strong repulsive force between
them52. In order to have numerical stability and accuracy in the conservation of energy, the
time step must be chosen at least an order of magnitude smaller than the smallest
vibrational period of the system52.
In protein simulations, the fastest intramolecular vibrational motions are the C-H, N-H and
O-H stretches (Figure 2.2). For these, a time step of ∆t = 0.5 – 1 fs is needed. In most
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simulations, these bond vibrations are not of interest per se and constraints can be applied
to the bond lengths and angles, making it possible to extend the time step to 2 fs 49.
SHAKE53 and LINCS54,55 are the constraint algorithms most widely used.

Figure 2.2 Range of timescale for atomistic MD simulations
Having fixed the time step, the timescales accessible in MD simulations will depend on the
size of the system, and the hardware and software used to run the simulations. Roughly one
billion arithmetic operations are needed at each time step for a system with one hundred
thousand atoms. A single high-end processor core would take thousands of years to
complete a millisecond long simulation. Fortunately, software that parallelizes MD force
calculations across multiple computer processors as well as GPUs has existed for nearly
three decades, becoming much more efficient and scalable in the past several years. The
widely used MD codes NAMD56, GROMACS57 and AMBER58 can now deliver a
performance of over 100 ns/day on commodity computer clusters in systems of ~10,000
atoms, with the number of processors needed scaling roughly linearly with the number of
atoms in the system59. A typical simulation (a moderately sized, solvated, globular protein)
has ~50,000 atoms.
There is a special-purpose supercomputer named Anton, designed by D. E. Shaw Research,
that has made possible to reach the millisecond-scale in all-atom simulations. Anton is able
to achieve this speed because it was specifically designed for MD simulations. It is the
result of an algorithm/hardware co-design process in which the choice of algorithms
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impacted the design of the hardware, and vice versa 60. While time on an older (2016) Anton
machine has been generously granted to the scientific community, access is still extremely
limited and is only available to some faculty at a U.S. academic or non-profit research
institution.

2.6

Coarse-graining methods

One way to substantially accelerate simulations at the cost of reduced accuracy, is the use
of coarse-grained models. In these, the original system is replaced by a simpler one, with
less degrees of freedom, effectively averaging over some chosen properties of microscopic
entities to form larger basic units61. Reducing the number of interactions that must be
computed smoothens the energy landscape, making them faster than all-atom simulations
(Figure 2.3)49. The specific acceleration attained by a CG model depends on the details of
the model used.

Figure 2.3 All-atom vs coarse-grained energy landscape. The flattening of the energy surface
in the coarse-grained model enables its efficient exploration. From Chem Rev, 2016 (Open
Access article under an ACS AuthorChoice License) 62.
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There are four conditions that degrees of freedom must meet in order to be eliminated in a
physically correct manner, such that a computationally efficient yet accurate CG model is
obtained:
1. they must be non-essential to the property of interest,
2. they must be large in number or computationally costly, so that the computational
gain is substantial enough to offset the loss in accuracy,
3. the interactions governing the degrees of freedom to be eliminated must be largely
decoupled from those which will be kept,
4. their elimination should allow a simple and efficient representation of the
interactions governing the remaining degrees of freedom63.
There are two fundamentally different approaches to designing a force field for CG models
for particle simulations, one is “physics-based” and the other is “knowledge-based”. In
general, a physics-based CG force field can be described by a similar formula as an allatom force field (Equation 2). However, during the coarse-graining process, some atoms
are removed and their degrees of freedom are averaged out. One must then introduce
explicitly the internal correlations between groups of atoms (now represented as united
atoms) in the form of multibody terms. Most approaches keep the distinction between local
energy terms and so-called contact potentials62. This philosophy of modeling is also known
as structure-based, systematic, hierarchical or bottom-up64,65. It often requires a timeconsuming parametrization procedure and has complex potential forms, resulting in lower
performance and thus less sampling66. Nevertheless, force fields such as the PLUM
model67 allow an accurate sampling of local conformations and can achieve a realistic α/β
content. The theoretical justification of structure-based coarse-graining is the Henderson
theorem68, which defines a one-to-one relationship between a set of radial distribution
functions and a set of pair potentials for CG sites.
In contrast, knowledge-based force fields are derived from the statistical analysis of
structural features observed in databases of experimental structures. Depending on the level
of coarse-grained representation, definition of the model force field and the complexity of
the databases being used, the final formula that defines the force field will be composed
from a significantly larger number of terms than an all-atom force field. Moreover, some
terms describe specific conditional combinations of bonds, angular and non-bonded
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interactions62. This method of modeling can also be found in the literature as buildingblock, thermodynamics-based or top-down. These models are often cheaper, due to simpler
potential forms and requiring only partial parametrization. However, their structural
accuracy is limited as the representation of the atomistic detail is suboptimal66.
One of the most widely used CG models is the knowledge-based Martini69–71 force field. It
was initially developed for lipids but since then, it has been extended to include proteins,
carbohydrates, DNA, RNA and small molecules. The Martini69–71 model relies on a fourto-one mapping scheme, where on average four non-hydrogen atoms are mapped to a single
CG bead (Figure 2.4). It has four main types of particles: polar, nonpolar, apolar and
charged. These types are in turn divided into subtypes according to their hydrogen-bonding
capabilities or their degree of polarity. This gives a total of 18 particle types 71. The model
was reparametrized in April 2021, and in contrast with previous versions, it defined a new
particle type specific for water. Although this new bead type enables the optimization of
water properties independently from other targets, structure-based CG models are more
suitable for applications that require finer details70.

Figure 2.4 Mapping between the chemical structure and the coarse grained model for
DPPC, cholesterol and benzene. The coarse-grained bead types which determine their
relative hydrophilicity are indicated. Reprinted with permission from Marrink et al71.
Copyright 2021 American Chemical Society.
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Coarse-grained representations have been successfully used to study protein folding
mechanisms72, conformational changes upon ligand binding, membrane proteins69 and the
self-assembly of protein/membrane and protein/detergent complexes73.
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3

About this thesis
3.1

Significance and aims

The primary aim of this work was to improve the understanding of the applicability of
different computational techniques to study globular and IDP proteins. To accomplish this,
two proteins were chosen as study targets: Triosephosphate isomerase (TIM) and Methyl
CpG binding protein 2 (MeCP2). Both proteins are targets for drug design.
TIM is an extensively studied globular protein and is often considered a “textbook” protein.
Its first crystal structure revealed the TIM barrel topology for the first time, which is an
eightfold repeat of (βα) units1. This structural motif is the most common enzyme fold and
is present in ~10% of all known proteins1–3. There is plenty of experimental data available
on this protein as well as a few computational studies4–12. TIM is essential for maintaining
life under anaerobic conditions and has been used as target for antiparasitic drugs13–15.
In contrast, MeCP2 is a protein whose full-length structure is not even known. The only
available structure contains solely ~17% of its amino acids16. MeCP2 was the first of the
methylated DNA binding protein (MBP) family to be identified17. It selectively binds CpG
dinucleotides and mediates transcriptional repression through interaction with histone
deacetylase and the corepressor SIN3A18,19. The malfunction of this protein causes the
neurodevelopmental disorder Rett syndrome20,21. Less is known about MeCP2 structure
compared to its functions because it is an intrinsically disordered protein (IDP). Circular
dichroism has shown that almost 60% of the protein is unstructured 22, and five out of its
six domains lack a stable tertiary structure23. The knowledge gap between structure and
function of this protein could potentially be bridged using computer simulations.
The findings should be useful for improving the general understanding of the use of
computational techniques for the study of biomolecules, as well as providing new insights
into the structure of TIM and MeCP2.
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3.2

Thesis outline

Chapters 4 and 6 represent individual, first author publications, in their unmodified forms.
While chapter 5 is not a first author publication, I carried out every computational
component of the work.
Chapter 4 describes a study of the globular protein TIM. All-atom simulations of three TIM
proteins (TcTIM, TbTIM and a chimeric protein) were performed. The residue interaction
networks of the amino acids in these trajectories were analyzed, as well as their electrostatic
interactions and the impact of simulation length on them. Our findings provide new insights
on the mechanisms that give rise to the different biophysical behaviors of these highly
similar proteins and underline the importance of long simulations.
The study of MeCP2 starts in chapter 5. We present simulations of the MBD domain in
solution and in the presence of a surface, in order to compare them with the experimental
setup of high-speed atomic force microscopy (HS-AFM). Chapter 6 contains the next step,
which was to complete the rest of the protein by ab initio modelling. Since an all-atom
simulation of this model is not enough to guarantee adequate sampling of its
conformational space, coarse-grained modeling was used to complement the atomistic
picture. The coarse-grained simulations sampled a conformation that had not been
observed in the all-atom simulation but that was in good agreement with HS-AFM data.
Together, chapters 5 and 6 provide a detailed conformational ensemble of MeCP2, which
is compatible with experimental data and can be the basis of further studies.
The major conclusions from this thesis and possible future directions are discussed in
chapter 7.
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4.1

Abstract

Homodimeric triosephosphate isomerases (TIM) from Trypanosoma cruzi (TcTIM) and
Trypanosoma brucei (TbTIM) have a markedly similar amino acid sequences and threedimensional structures. However, several of their biophysical parameters, such as their
susceptibility to sulfhydryl agents and their reactivation speed after being denatured, have
significant differences. The causes of these differences were explored with microsecondscale molecular dynamics (MD) simulations of three different TIM proteins: TcTIM,
TbTIM and a chimeric protein, Mut1. We examined their electrostatic interactions and
explored the impact of simulation length on them. The same salt bridge between catalytic
residues Lys 14 and Glu 98 was observed in all three proteins, but key differences were
found in other interactions that the catalytic amino acids form. In particular, a cation-π
interaction between catalytic amino acids Lys 14 and His 96, and both a salt bridge and a
hydrogen bond between catalytic Glu168 and residue Arg100, were only observed in
TcTIM. Furthermore, although TcTIM forms less hydrogen bonds than TbTIM and Mut1,
its hydrogen bond network spans almost the entire protein, connecting the residues in both
monomers. This work provides new insight on the mechanisms that give rise to the
different behaviour of these proteins. The results also show the importance of long
simulations.

4.2

Introduction

One of the most common structural motifs in proteins is the triosephosphate isomerase
(TIM) barrel, which is present in ~10% of all known proteins and is the most common
enzyme fold in the Protein Data Bank (PDB) database1–4. TIM is an enzyme which takes
part in the fifth step of glycolysis by interconverting glyceraldehyde 3-phosphate into
dihydroxyacetone phosphate. The TIM barrel consists of an eightfold repeat of (βα) units
in such a way that β-strands in the inside are surrounded by α-helices on the outside. TIM
is present in almost all organisms and is usually found as a dimer, although it can form a
tetramer in some extremophile organisms5–8. It is completely active only in the dimeric
form even though each monomer contains the catalytic residues (N12, K14, H96 and
E168). The catalytic residues are strictly conserved throughout the whole TIM family1,9,10.
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TIM is essential for maintaining life under anaerobic conditions and, consequently, it has
been used as a target for drug design when dealing with human parasites 11–13.
There are multiple instances in which homologous enzymes with high similarity have
significant differences in their biophysical parameters14–17. This is exemplified by the
triosephosphate isomerases of Trypanosoma cruzi (TcTIM), the parasite that causes
Chagas’ disease, and Trypanosoma brucei (TbTIM), causative agent of the African
sleeping sickness. They have a sequence identity of 73.9% and a sequence similarity of
92.4%18 (Fig. 4.1). Previous works have found significant differences in their susceptibility
to sulfhydryl agents, reactivation speed after being denatured with chemical agents such as
guanidine hydrochloride, and their proteolysis susceptibility with subtilisin 16,18–20.
Interestingly, a study of TcTIM and TbTIM by Rodríguez-Bolaños et al.21 showed that it
is sufficient to mutate 13 amino acids on TbTIM to obtain TcTIM-like behaviour in
reactivation experiments. Circular dichroism indicated that the chimeric proteins had the
same fold as the native, however, the role that these mutations have on the structure and
dynamics of the proteins is not well understood.
For many years, studies have focused on the interaction between TIM proteins and
benzothiazoles, which have been found to deactivate the enzyme13,22,23. While there is a
plethora of experimental data, there are very few MD simulations of TcTIM and TbTIM in
the absence of ligands. Some of the simulations are only 40-60 ns long, and thus cannot
capture phenomena that occur in longer timescales24–26. There is only one study in the
microsecond scale. In that Dantu and Groenhof use a combination of QM/MM and crystal
unit cell simulations27. However, this study focuses on the effect of binding of substrates
in loops 5, 6 and 7. The most comprehensive study on TIM so far used conventional MD
and enhanced sampling techniques to characterize the motion of loops 6 and 728. This study
showed that loop 6 does not follow a simple two-state rigid-body transition as previously
thought. However, it did not explore in detail the interactions between the two monomers.
The simulations that report the root-mean-square fluctuation (RMSF) of TIM proteins have
consistently found the highest RMSF values in loops 5 and 6 22,24,25, which is in good
agreement with our work.
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Here we present microsecond-scale all-atom simulations of TcTIM, TbTIM and a chimeric
TbTIM with the 13 mutations as identified by Rodríguez-Bolaños et al21. A conserved salt
bridge between catalytic residues Lys 14 and Glu 9829,30 was observed in all three proteins.
In contrast, a cation-π interaction between catalytic amino acids Lys 14 and His 96, and
both a salt bridge and a hydrogen bond between catalytic Glu 168 and Arg 100 were only
observed in TcTIM. Furthermore, TcTIM and TbTIM exhibited different hydrogen bond
networks, with the chimeric protein behaving similar to TbTIM. The hydrogen bond
network observed in these proteins helps to explain why regions 1, 4 and 8 become more
rigid when the dimer is formed.

Figure 4. 1 Alignment of TcTIM and TbTIM sequences with the secondary structure elements
marked as lines (loops), β-strands (arrows) and α-helices (cylinders). The colors in each motif
correspond to the 3D structure below it. The differences in the amino acids are highlighted
in gray and the catalytic residues in red.
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4.3

Materials and methods

All-atom MD simulations were performed on three TIM proteins: 1) the TIM from T.
brucei (TbTIM), 2) the TIM from T. cruzi (TcTIM), and 3) a chimeric protein: [TcTIM:2;
TbTIM:1,3-8; Q18E, E23P, D26E, S32T, I33F, N34D] henceforth referred to as Mut1.
Each protein was simulated as a dimer. The initial structures were taken from the Protein
Data Bank (PDB ids: 1TCD31 and 5TIM32) and any missing side chains were completed
using the whatif web server33. Mut1 was built using TbTIM as template and mutating the
required amino acids using Pymol34.
Each protein was placed in a dodecahedral box in which the distance from the edges of the
box to every atom in the protein was at least 1 nm. The box was solvated with explicit
water and 150 mM of NaCl was added to reproduce physiological conditions. Counterions
were added to keep the overall charge neutrality of the systems, 6 Cl- ions for the TcTIM
and 10 Cl- ions for both 5TIM and Mut1. All simulations were performed using
GROMACS 2016.335 with the TIP3P water model36 and the CHARMM36m force field37.
Each system was first energy minimized using the method of steepest descents and preequilibrated at constant particle number, temperature and volume, for 100 ps. The preequilibration was followed by a production run with a time step of 2 fs. The Lennard-Jones
potential was truncated using a shift function between 1.0 and 1.2 nm. Electrostatic
interactions were calculated using the particle-mesh Ewald method (PME)38,39 with a real
space cut-off of 1.2 nm. The temperature was set to 310 K with the V-rescale algorithm40
and pressure was kept at 1 atm using the Parrinello-Rahman barostat41. Bonds involving
hydrogens were constrained using the Parallel Linear Constraint Solver (P-LINCS)
algorithm42. The root-mean-square deviation (RMSD) was used to monitor equilibration.
Since the RMSD for TcTIM kept increasing during the first microsecond, the simulations
were extended to 3 μs. We will return to this issue later in Results.
Trajectory analyses were performed using Gromacs built-in tools35, MDAnalysis43,44 and
the VMD plug-ins Salt bridges45 and RIP-MD46. RIP-MD generates residue interaction
networks (RINs) from MD trajectory files. In a RIN, the nodes of the network represent
amino-acid residues and the connections between them depict non-covalent interactions.
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These include hydrogen bonds, salt bridges, cation-π, π–π, arginine–arginine, and Coulomb
interactions. RIP-MD starts with a MD trajectory and the parameters defining the
interactions as input. It then searches for interactions between all atoms in each snapshot
of the trajectory. Finally, it generates a consensus RIN where edges exist if they are present
in at least a given percentage of the snapshots. For our study, we used a 30% threshold.

4.4

Results

We performed MD simulations on three different TIM proteins: TcTIM, TbTIM and Mut1.
Figure 4.2 shows that the RMSD of all three systems increase throughout the first 1500 ns,
after which they stabilized. For this reason, the simulations were extended to 3 μs and all
reported averages were calculated during the last microsecond of the trajectories.

Figure 4.2 Root-mean-square deviation with respect to the crystal structure. RMSD increases
throughout the first 1500 ns before stabilizing.

The root-mean-square fluctuations (RMSF) of most of the residues in the three proteins are
very similar (Fig. 4.3). The main differences appear at the highest peaks, which are located
at residues 133-137 (loop 5) and 173-178 (loop 6) in both monomers. The amino acids in
loop 6 correspond to the catalytic loop. This loop has a “phosphate gripper” motif47 which
is likely engaged in substrate binding and product release, as its opening and closing motion
has a rate constant that closely matches the turnover time for catalysis48,49. TcTIM is the
only protein with peaks at loops 5 and 6 in monomer A and TbTIM is the only protein with
a peak in loop 5 monomer B. All three proteins have a peak in loop 6 monomer B, albeit
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the peak in TbTIM is almost two times larger than in the other two systems. TcTIM is the
only protein in which the first residues of monomer B have a very low RMSF value,
indicating an interaction with monomer A.
In a previous computational study of TcTIM25, loops 5 and 6 were reported to have the
largest fluctuations. This study used GROMOS96 (43a2) 50, a united-atom force field and
the SPC water model51. The fact that the same results were obtained with two very different
force fields (GROMOS and CHARMM) underlines their robustness and their
independence of the chosen force field. All the other main peaks correspond to amino acids
located in loops with the exception of residues 236-239, which span the short helix in
region 8.

Figure 4.3 Root mean square fluctuations for the last microsecond. Since each protein was
simulated as a dimer, the color bar at the bottom distinguishes the residues in monomer A
(purple) from those in monomer B (yellow). The main peaks are located at loops 5 and 6 in
each monomer.

The number of contacts between monomers, defined as amino acids whose Cβ atoms (Cα
for glycine) are within 0.8 nm distance, is shown in Figure 4.4. Even though a protein
residue-residue contact is not uniquely defined, this definition captures all possible
interactions between two residues and it has been used in a number of previous studies 52–
55

. The number of contacts changes for both TcTIM and Mut1 during the first microsecond
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before stabilizing. In contrast, the number of contacts between TbTIM’s monomers
fluctuated throughout the entire simulation. The average number of contacts between
monomers during the last microsecond is 119 for TcTIM, 89 for TbTIM and 116 for Mut1.
This is in good agreement with previous experiments, since the number of contacts between
monomers can be related to its thermal stability and TcTIM has higher thermal stability
than TbTIM21.

Figure 4.4 Number of contacts between monomers. Residues are considered to be in contact
if their respective Cβ atoms (Cα for glycine) are less than 0.8 nm apart. The number of
contacts in TcTIM and Mut1 decreases over the first microsecond, increases over the next
200 ns and then stabilizes. In TbTIM, they decrease during the first half of the simulation
and increase again after 1500 ns. Solid lines are Bézier curves that interpolate the data.

In order to identify if the systems were in the open or closed conformations, the minimum
distance between loop 6 (residues 170-180) and loop 7 (residues 211-216) was measured
(Fig. 4.5, S4.1). Five different states were sampled in TcTIM, with distances 0.18, 0.28,
0.50, 0.67 and 0.80 nm. Only the first three states were observed in TbTIM and Mut1. It
was previously reported that loop 6 can sample multiple conformational states with the tip
of the loop moving ~0.7 nm between the fully open and fully closed conformations28. This
is in good agreement with the difference between the two extremes observed in the current
TcTIM simulation. TbTIM fluctuated the most between states, and while Mut1 also
showed many fluctuations, its loop in monomer B remained in the fully closed
conformation for the last microsecond of the simulation. The cross-correlation between the
open-close conformation of the two monomers decayed to zero during the simulation,
indicating that the movement of these loops is independent between monomers.
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Figure 4.5 Minimum distance between loops 6 and 7 in TcTIM for monomer A (purple) and
monomer B (yellow). Dashed lines mark the five different states sampled by the loops. Inset:
cross-correlation between the loop state of the two monomers. Right: alignment of the open
(gray) and closed (black) conformations. Loop 6 is shown in red for the closed conformation
and in blue for the open conformation, loop 7 is shown in orange (closed) and purple (open).

Electrostatic interactions
We used the RIP-MD46 plugin for VMD45 to analyze the last 2 μs of each trajectory and
to compute the following electrostatic interactions between all residues: salt bridges,
cation-π interactions, π-π interactions and hydrogen bonds. No arginine-arginine
interactions were found in the simulations. We will describe these interactions in the
section below in more detail, but Table 1 summarizes the parameters defining them.

Table 4.1 Summary of interactions defined in RIP-MD

Hydrogen
bonds

Salt bridges

dist (donor, acceptor) ≤ d

d=3Å

⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗
⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗ ) ≥ a
θ (𝑪
− 𝑯, 𝒂𝒄𝒄𝒆𝒑𝒕𝒐𝒓

a = 120°

Contacts between NH/NZ groups of Arg/Lys

d=6Å
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and OE/OD in Asp/Glu ≤ d
Cation-π

dist (aromatic ring, cation) ≤ d

d=6Å

interactions

⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗
θ (𝑛𝑜𝑚𝑎𝑙
𝑣𝑒𝑐𝑡𝑜𝑟 𝑟𝑖𝑛𝑔, ⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗⃗
𝑟𝑖𝑛𝑔 𝑐𝑒𝑛𝑡𝑒𝑟 − 𝑐𝑎𝑡𝑖𝑜𝑛) = a

a ϵ [0°, 60°] or
a ϵ [120°, 180°]

π-π

dist (aromatic ring, aromatic ring) ≤ d

d=7Å

dist (guanidine, guanidine) ≤ d

d=5Å

interactions

Arg-Arg

From the three proteins, only TcTIM had cation-π interactions (Fig. S4.2). These
interactions were defined between the geometric center of the ring in the aromatic residue
and the charged atom in the second residue, with a cutoff distance of 0.6 nm. This threshold
was chosen because 99% of significant cation-pi interactions occur within a distance of 0.6
nm56. The only cation-π interaction between monomers occurs between amino acids Tyr
103 in monomer A and Arg 99 in monomer B. Figure 4.6 shows the distance that defines
this cation-π interaction throughout the simulation. The distance fluctuates throughout time
but remains within the limits that define the cation-π interaction during most frames in the
last 1,500 ns of the simulation.

67

Figure 4.6 Cation- π interaction between Tyr 103 in monomer A and Arg 99 in monomer B
in TcTIM. This interaction is defined by the distance between the geometric center of the
aromatic residue in tyrosine and the charged atom in arginine, with a cutoff distance of 0.6
nm. This interaction was only observed in TcTIM. Right: these amino acids are located in
region 4. A red line marks the threshold that defines the cation-π interaction.

Π-π interactions were defined with the distance between the geometric centers of the rings
in the aromatic amino acids, with a cutoff distance of 0.7 nm. The distance between two
interacting aromatic rings is geometry dependent and varies between 0.45 and 0.7 nm57.
All three systems presented π-π interactions (Fig. S4.3). Out of the 14 π-π interactions in
TcTIM, four occurred at the interface between monomers. TbTIM only presented five π-π
interactions and the mutant had four, two of which occurred at the interface. Interestingly,
two of the π-π interactions in the mutant correspond to interactions in TcTIM and the other
two to interactions in TbTIM.

Residue interaction networks
In RIP-MD46, salt bridges are treated as a contact between two heavy atoms of opposite
charge with a distance threshold of 0.6 nm46,58. The same salt bridges were observed in the
three proteins: between Glu 78 (Glu 77 in TbTIM) and Arg 99 (Arg 98 in TbTIM) of both
monomers (Fig. S4.4). Residue Arg 55 forms a salt bridge with residue 27 from the same
monomer, in both monomers in TcTIM. Since RIP-MD46 does not provide the time
dependence of the salt bridges, we used the Salt Bridge VMD plugin45 to calculate them.
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This plugin uses a different cutoff distance (0.32 nm) to define a salt bridge, however, as
long as the interacting atoms are within the threshold in one frame, the program outputs
the distance between them as a function of time. Figure 4.7 illustrates the fluctuations of
the distance between atoms that form salt bridges. The interaction between Glu 27 and Arg
55 in TcTIM fluctuates considerably and the salt bridge is defined in only a portion of the
frames. In contrast, the salt bridge between Glu 98 and Lys 14 stays well within the limit
that defines this interaction throughout the whole simulation.

Figure 4.7 Salt bridges in TcTIM between Glu27 monomer A and Arg55 monomer A (A), and
between Glu98 monomer A and Lys14 monomer A (B). These interactions were computed
using the Salt Bridges plugin for VMD45. Right: 3D location of the amino acids. Residues
Glu27 and Lys14 are shown in red (region 1), Arg55 in green (region 2) and Glu98 in yellow
(region 4). A red line marks the threshold that defines the salt bridge interaction.

Hydrogen bonds were defined using a cutoff radius of 0.3 nm for atoms whose acceptorhydrogen-donor angle is greater than 120°59. The average number of hydrogen bonds over
the last microsecond was 345 for TcTIM and 369 ± 1% for TbTIM and Mut1 (Fig. 4.8).
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Figures S4.5-S4.15 show the hydrogen bond networks in the three proteins. For clarity,
hydrogen bonds formed between neighboring amino acids (less than 4 residues apart) have
been removed from the graphs. Even though TcTIM forms less hydrogen bonds than
TbTIM, they connect amino acids in a network that involve more interactions between
monomers and extends throughout the whole protein (Fig. S4.16).

Figure 4.8 Total number of intramolecular hydrogen bonds in each simulation. Solid lines
are Bézier curves that interpolate the data. Hydrogen bonds were defined with a cutoff radius
of 0.3 nm for atoms whose acceptor-hydrogen-donor angle is greater than 120°59.

Species-specific inhibition of TIMs can be achieved by targeting a non-conserved amino
acid (Cys15) that lies at the dimer interface and which is important for catalysis 11. The
susceptibility of TcTIM to thiol agents is approximately 40 times higher than that of
TbTIM60. Figure S4.17 shows the amino acids that form hydrogen bonds with Cys15
(Cys14 in TbTIM). Hydrogen bonds were determined with a cutoff angle of 30° for the
hydrogen-donor-acceptor angle and a cutoff radius of 0.3 nm; OH and NH groups were
regarded as donors, and O and N as acceptors. The residues that participate in hydrogen
bonds with this cysteine change after the first microsecond in all three systems. In
particular, those formed with residues Gly 73 and Ala 74 in TcTIM, with residue Ala 236
in TbTIM and with residues Phe 75 and Ser 80 in Mut1. Interestingly, TbTIM’s Cys14
interacts with residues in region 8 from the same monomer, while TcTIM and Mut1’s
Cys15 interact with residues from region 3 in the other monomer. Fluctuations in the
hydrogen bond network for Cys14/15 can only be noticed in simulations longer than 1 μs.
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Only the hydrogen bond between Cys15 monomer B and Phe75 monomer A in TcTIM was
identified as such by RIP-MD45, the other interactions were identified as Cα contacts.

4.5

Discussion

Biological relevance
TIM has four catalytic residues: Asn12, Lys 14, His 96 and Glu 1682,10. TcTIM is the only
protein with cation-π interactions and one of them is between two of the catalytic residues:
His 96 and Lys 14 (Fig. S4.2). Cation-π interactions can enhance binding energies by 2–5
kcal/mol, making them competitive with hydrogen bonds61. Another interaction only found
in this protein occurs between catalytic Glu 168 and residue Arg 100, they form both a salt
bridge and a hydrogen bond (Fig. S4.4, S4.5). In contrast, a salt bridge between catalytic
Lys 14 (13 in TbTIM) and residue Glu 98 (97 in TbTIM) was observed in all three proteins
(Fig. S4.4). This is a conserved salt bridge that has been observed in several crystal
structures29,30. Lys 14 is also involved in the main network of hydrogen bonds in TcTIM.
It forms a hydrogen bond with its neighbor, catalytic Asn 12, which in turn forms a
hydrogen bond with residue Thr 76 from the other monomer and with the other catalytic
residue, His 96 (Fig. S4.5). Similarly, Mut1 forms a hydrogen bond between two of the
catalytic residues, Lys 14 and Asn 12, which in turn forms a hydrogen bond with residue
76 from the other monomer. However, unlike TcTIM, these residues are not connected to
others in the network (Fig. S4.9). In both Mut1 and TbTIM, catalytic Asn 12 (Asn 11 for
TbTIM) forms a hydrogen bond with residue Val 234 (Val 233 in TbTIM) and Lys 14 (Lys
13 in TbTIM) forms one with Gly 236 (Gly 235 in TbTIM) (Fig. S4.10, S4.11, S4.13,
S4.15). Catalytic Glu 168 forms three hydrogen bonds in TcTIM: with Arg 100, Val 128
and Glu 130, but it only forms the last two bonds in TbTIM and Mut1 (Fig. S4.5, S4.11,
S4.12, S4.14, S4.15).
Regions 1, 4 and 8 are known to become more rigid when the dimer is formed 30. Region 1
forms several hydrogen bonds with region 3 of the opposite monomer. TcTIM forms six
of these bonds at the interface, while TbTIM and Mut1 form only two (Fig. S4.5, S4.6,
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S4.9). Of all regions, region 4 had the highest number of salt bridges, comprising 13
residues in TcTIM, 11 in TbTIM and 10 in Mut1 (Fig. S4.4). Salt bridges between Arg 99
(Arg 98 in TbTIM) and Glu 78 (Glu 77 in TbTIM) involving both monomers were found
at the interface of all three proteins. Only TcTIM formed salt bridges in region 8, two in
each monomer.
The same salt bridge between residues Arg 192 (Arg 191 in TbTIM) and Asp 228 (Asp
227 in TbTIM) was observed in the two native proteins but not in Mut1 (Fig. S4.4). Since
it has been shown that this conserved bridge is important for the efficient folding of TIM62,
we expect that Mut1 will have a low recovery of activity in denaturation and refolding
experiments.
TcTIM had a high RMSF value in loops 5 and 6 monomer A, but a low value in the same
loops in monomer B (Fig. 4.3). Five amino acids in monomer B are involved in salt bridges,
but only one in monomer A. Three amino acids from region 6 form salt bridges in monomer
A, and four in monomer B. One of them is catalytic Glu 168. Similarly, TbTIM forms more
salt bridges in monomer A loop 5, than in monomer B. Six residues from loop 5 monomer
A form salt bridges but only three in monomer B. Only one residue in loop 6 monomer B
forms a salt bridge (Fig. S4.4). Mut1 has a similar number of residues from loop 5 involved
in salt bridges in both monomers, which explains why neither one of them has a high RMSF
value. Salt bridges can vary in strength from weak (0.5 kcal/mol) to strong (3–5 kcal/mol)
and play an important role in structure stabilization63. This may explain why the chimeric
protein has a lower catalytic efficiency than its parent protein14.
The RMSF of TcTIM residues (Fig. 4.3) showed low values for the end of each monomer.
This is explained by the network of hydrogen bonds (Fig. S4.7, S4.8) Amino acids at the
end of the chain are connected to other residues forming a chain of hydrogen bonds that is
not observed in the other two proteins. Furthermore, TcTIM has more interactions between
monomers than the other two proteins. Some of these interactions were found in the mutant
but not on TbTIM. This may explain why TcTIM has higher thermal stability even though
it forms less hydrogen bonds than TbTIM26. Based on this, we expect that Mut1 would
have a thermal stability higher than TbTIM but lower than TcTIM.
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The need for long simulations
While the RMSD helped to identify the need to increase the simulation time of all three
systems, it is not the only quantity where this issue can be noticed. When the RMSF of the
first 200 ns of the simulation is compared with the RMSF of the last 200 ns of each
simulation, noticeable differences can be observed (Fig. 4.9, S4.18, S4.19). One of the two
main peaks in TcTIM and in the RMSF of TbTIM do not even appear at the beginning of
the simulations. Furthermore, fluctuations in many amino acids decrease, which help to
highlight the relevance of the main peaks. In contrast, when one compares the last 200 ns
of the simulation with the last microsecond of the trajectory, differences are considerably
smaller. An exception to this appears in loop 6 monomer B of TbTIM, which is only
observed when the average is calculated over the last microsecond of the simulation.

Figure 4.9 Changes over time in the root mean square fluctuations of the residues of TcTIM.
A) RMSF of the first 200 ns of the simulation vs the last 200 ns, and B) RMSF of the last
microsecond of the trajectory vs the last 200 ns. The peak in loop 5 of monomer A does not
appear at the beginning of the trajectory and fluctuations in the minor peaks decrease at
longer times. The color bar at the bottom of figure B distinguishes the residues in monomer
A (purple) from those in monomer B (yellow).

One way to monitor convergence of simulations is to plot the average of a quantity over
different time intervals. If the average changes with different time windows, then the
system is not properly equilibrated. Figure 4.10 shows the number of intramolecular
hydrogen bonds for the TcTIM trajectory. Horizontal lines mark the averages taken over
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different time windows. The average for the first 500 ns is 7% higher than that of the last
500 ns. The average over the last microsecond of the trajectory equals the average over the
last 500 ns (345 hydrogen bonds), which indicates that the trajectory has stabilized over
the last microsecond.

Figure 4.10 Number of hydrogen bonds in TcTIM. Convergence (horizontal lines) is reached
around 2 μs. Averaging over the last 500 ns or over the last microsecond of the simulation
produces the same average (345 hydrogen bonds; the lines overlap). Blue: moving average.

In order to find how the hydrogen bond networks changed with time, we used the Gromacs
built-in cluster tool to generate clusters for the first and last 500 ns of the simulations. The
clusters were generated using the gromos method with a RMSD cutoff of 0.2 nm. We then
used RIP-MD46 to analyze the RINs in the representative structure of the most populated
cluster. Figures S4.20 and S4.21 show the most significant changes in TcTIM. At the
beginning of the simulation there is little connectivity between the main hydrogen bond
networks of each monomer, when residues 75, 78 and 99 in monomer B interact with
residues 15 and 103 in monomer A, these two networks merge into one (Fig. 4.11).
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Figure 4.11 Changes in the hydrogen bond network of TcTIM. Interface between monomers
(A) at the beginning and (B) at the end of the simulation. Residues Phe 75, Glu 78 and Arg 99
in monomer B (blue) change their interaction with residues in monomer A (orange).

Changes in protein dynamics are in turn reflected in the interactions between amino acids.
Some interactions appeared after the first 500 ns of the simulation, e.g., the π-π interaction
between residues 187 and 210 in monomer A of TbTIM, and others became more stable
only after the first microsecond of the simulation, e.g., the π-π interaction between residues
36 and 224 of monomer B in TcTIM (Fig. 4.12).
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Figure 4.12 π-π interactions in TcTIM between residues His 36 and Tyr 224 of monomer B
(A) and in TbTIM between residues His 187 and Tyr 210 in monomer A (B). A red line marks
the threshold that defines the π-π interaction. At the right side of each graph, conformation
changes between the first frame (green and blue) and the last frame (red and purple) of each
simulation are shown. The interaction in TcTIM was not observed during the first 500 ns of
the simulation. The interaction in TbTIM was observed since the beginning but it only
become stable after the first microsecond.

4.6

Conclusions

We have performed molecular dynamics simulations on three different TIM proteins:
TcTIM, TbTIM and a chimeric protein, Mut1. We examined the different electrostatic
interactions that occur in these proteins: salt bridges, cation-π interactions, π-π interactions
and hydrogen bonds, and also explored the impact of simulation length on them. Some of
these interactions appeared only after the first microsecond of the simulation, and
convergence of the number of hydrogen bonds was only reached in the last of the 3 μs of
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the simulation. Although TcTIM forms less hydrogen bonds than TbTIM and Mut1, they
form a network that spans almost the entire protein, connecting the residues in both
monomers. Key differences were found in the interactions that the catalytic amino acids
form, such as a cation-π interaction between catalytic amino acids Lys 14 and His 96, only
observed in TcTIM, but a salt bridge between catalytic residue Lys 14 and Glu 98 was
observed in all three proteins. Further experiments will be required to confirm our
hypothesis on the thermal stability of Mut1.

4.7

Supplemental information

Figure S4.1 Minimum distance between loops 6 and 7 in TbTIM (A) and Mut1 (B) for
monomer A (purple) and monomer B (yellow). Dashed lines mark the two different states
sampled by the loops. Inside: cross-correlation between the loop state of the two monomers.
Right: alignment of the open (gray) and closed (black) conformations. Loop 6 is shown in red

77

for the closed conformation and blue for the open conformation, loop 7 is shown in orange
(closed) and purple (open).

Figure S4.2 Cation-π interactions for TcTIM throughout the last 2 s of the simulation.
Amino acids in monomer A are shown in green and residues in monomer B in red. Each node
is coloured according to the color scheme for regions in Fig. 4.1 of the main text. The catalytic
residues are written in red text.

Figure S4.3 π-π interactions for TcTIM, TbTIM and Mut1 throughout the last 2 s of the
simulations. Amino acids in monomer A are shown in green and residues in monomer B in
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red. Each node is coloured according to the color scheme for regions in Fig. 4.1 of the main
text.

Figure S4.4 Salt bridges for TcTIM, TbTIM and Mut1 throughout the last 2 μs of the
simulations. TcTIM forms more salt bridges than the other two proteins. Amino acids in
monomer A are shown in green and residues in monomer B in red. Each node is coloured
according to the color scheme for regions in Fig. 4.1 of the main text. The catalytic residues
are written in red text.
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Figure S4.5 Main hydrogen bond network in TcTIM throughout the last 2 s of the
simulation. Each node is coloured according to the color scheme for regions in Fig. 4.1 of the
main text. The catalytic residues are written in red text.
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Figure S4.6 Hydrogen bonds in TcTIM throughout the last 2 s of the simulation. These
hydrogen bonds are found in both monomers. Amino acids in monomer A are shown in green
and residues in monomer B in red. Each node is coloured according to the color scheme for
regions in Fig. 4.1 of the main text.
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Figure S4.7 Hydrogen bonds in TcTIM throughout the last 2 s of the simulation. These
hydrogen bonds are found in both monomers. Amino acids in monomer A are shown in green
and residues in monomer B in red. Each node is coloured according to the color scheme for
regions in Fig. 4.1 of the main text.
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Figure S4.8 Hydrogen bonds in monomer B throughout the last 2 s of the TcTIM simulation.
Each node is coloured according to the color scheme for regions in Fig. 4.1 of the main text.

Figure S4.9 Hydrogen bonds involving amino acids at the interface between monomers in
Mut1 and TbTIM throughout the last 2 s of the simulations. Amino acids in monomer A are
shown in green and residues in monomer B in red. Each node is coloured according to the
color scheme for regions in Fig. 4.1 of the main text. The catalytic residues are written in red
text.
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Figure S4.10 Hydrogen bonds in Mut1 throughout the last 2 s of the simulation. These
hydrogen bonds are found in both monomers. Amino acids in monomer A are shown in green
and residues in monomer B in red. Each node is coloured according to the color scheme for
regions in Fig. 4.1 of the main text. The catalytic residue is written in red text.
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Figure S4.11 Hydrogen bonds in monomer A throughout the last 2 s of the Mut1 simulation.
Each node is coloured according to the color scheme for regions in Fig. 4.1 of the main text.
The catalytic residues are written in red text.

Figure S4.12 Hydrogen bonds in monomer B throughout the last 2 s of the Mut1 simulation.
Each node is coloured according to the color scheme for regions in Fig. 4.1 of the main text.
The catalytic residue is written in red text.
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Figure S4.13 Hydrogen bonds in TbTIM throughout the last 2 μs of the simulation. These
hydrogen bonds are found in both monomers. Amino acids in monomer A are shown in green
and residues in monomer B in red. Each node is coloured according to the color scheme for
regions in Fig. 4.1 of the main text. The catalytic residues are written in red text.

86

Figure S4.14 Hydrogen bonds in monomer A throughout the last 2 μs of the TbTIM
simulation. Each node is coloured according to the color scheme for regions in Fig. 4.1 of the
main text. The catalytic residue is written in red text.
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Figure S4.15 Hydrogen bonds in monomer B throughout the last 2 μs of the TbTIM
simulation. Each node is coloured according to the color scheme for regions in Fig. 4.1 of the
main text. The catalytic residues are written in red text.

Figure S4.16 Main hydrogen bond networks throughout the last 2 μs for A) TcTIM and B)
TbTIM. Amino acids in monomer A are shown in green and residues in monomer B in red.
Hydrogen bonds in TcTIM connect amino acids in a network that involves many interactions
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between monomers and extends throughout the whole protein, in contrast with TbTIM,
whose networks are contained within each monomer and involve fewer residues.

Figure S4.17 Hydrogen bonds in Cys 14/15 monomer A (left) and monomer B (right) in: A)
TcTIM, B) TbTIM and C) Mut1. This cysteine forms hydrogen bonds with region 3 of the

89

other monomer in TcTIM and Mut1 and forms hydrogen bonds in region 8 of the same
monomer in TbTIM.

Figure S4.18 Changes over time in the root mean square fluctuation (RMSF) of the TbTIM
simulation. RMSF of the first 200 ns of the simulation vs the last 200 ns (A), and RMSF of the
last microsecond of the trajectory vs the last 200 ns (B). The color bar at the bottom of figure
B distinguishes the residues in monomer A (purple) from those in monomer B (yellow). There
are no significant peaks in the RMSF of the beginning of the trajectory. The last 200 ns of the
simulation failed to capture the peak at loop 6 monomer B.

Figure S4.19 Changes over time in the root mean square fluctuation (RMSF) of the Mut1
simulation. RMSF of the first 200 ns of the simulation vs the last 200 ns (A), and RMSF of the
last microsecond of the trajectory vs the last 200 ns (B). The color bar at the bottom of figure
B distinguishes the residues in monomer A (purple) from those in monomer B (yellow).
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Fluctuations at the minor peaks decreased with time and the peak at loop 6 monomer B (red
arrow) increased.
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Figure S4.20 Main hydrogen bond networks for TcTIM in the most populated cluster of the
first 500 ns of the simulation. There is a different network for each monomer. Amino acids in
monomer A are shown in green and residues in monomer B in red.
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Figure S4.21 Hydrogen bond networks for TcTIM in the most populated cluster of the last
500 ns of the simulation. The residues in both monomers are connected through a single
network of hydrogen bonds. Highlighted in blue are the residues at the interface of the
hydrogen bond network (Fig. 4.11 in the main text). Amino acids in monomer A are shown
in green and residues in monomer B in red.
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5.1

Abstract

Methyl-CpG binding protein 2 (MeCP2) is a chromatin regulatory protein essential for
brain development and activity in vertebrates. Specific missense and nonsense mutations
in MeCP2 lead to the neurodevelopmental disorder, Rett syndrome (RTT). To understand
the structure and dynamics of MeCP2 and gain insight into the molecular basis of RTT, we
characterized MeCP2 properties using high speed atomic force microscopy and solutionstate approaches. MeCP2 is an intrinsically disordered protein that displays highly dynamic
behavior. MeCP2 transitions between a fully extended dumbbell-like structure with the
methyl DNA binding domain (MBD) and C-terminal domain (CTD) at the extremities, and
a compact structure where the MBD and CTD interact in cis. The MBD within the full
length protein equilibrates between unfolded and well folded states. MBD−CTD
interactions stabilize the MBD in its folded state and are essential for MeCP2 plasticity.
The R106W, R133C, F155S and T158M RTT mutations all showed aberrant MBD
dynamics compared to wild type. Our results indicate that MBD−CTD interactions in cis
and the unfolding/refolding transition of the MBD are important features of MeCP2
structure that become dysregulated in RTT.

5.2

Introduction

MeCP2 is a 53 kD nuclear protein found in large amounts in the lung, spleen, and especially
the brain of vertebrates. MeCP2 is named for its ability to selectively bind methylated DNA
(1), although it can bind to unmethylated DNA (2, 3). MeCP2 has important roles in both
neurodevelopment and adult brain function, with specific effects on transcription
documented in the hypothalamus, cerebellum, and hippocampus (4). The importance of
MeCP2 to normal brain function is further underscored by the finding that loss-of-function
mutations in the X-linked MeCP2 gene cause Rett syndrome (RTT), a severe
neurodevelopmental disorder. Girls with RTT develop normally until the age of 6−18
months, and then begin to lose language and fine motor skills. Further regression results in
a host of serious neurological and cardiac symptoms, including intellectual disability,
motor impairment, seizures, and characteristic hand wringing (4). Consequently, there has
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been intense interest in deciphering the molecular mechanisms through which MeCP2
influences cellular function in the normal and disease states. Much attention has been
focused on the role of MeCP2 as a methyl DNA binding transcriptional repressor (5). In
support of this idea, MeCP2 directly interacts with the nuclear co-repressor NCoR/SMRT
in vitro and in vivo and many RTT mutations disrupt this interaction (5). However,
transcriptomics studies in mouse models have shown that loss of MeCP2 alters the
expression of a large number of genes, roughly half of which are upregulated and half
downregulated, and the magnitude of these changes are small (6). To explain these results,
MeCP2 has been proposed to be a global regulator of transcription acting through effects
on chromatin architecture (6).
Less is known about MeCP2 structure compared to its functions. Full-length MeCP2
contains 486 amino acids and is a monomer in solution (7). Early studies identified two
functional domains, the methyl DNA binding domain (MBD, residues 78−163) and the
transcription repression domain (TRD, residues 207−309) (8). This led to the proposed
domain organization shown in Fig. 5.1A, where residues 1−77 were labeled the N-terminal
domain (NTD), residues 164−206 the intervening domain (ID) and residues 310−486 the
C-terminal domain (CTD). Structure-based evidence for the same domain architecture was
obtained after limited protease digestion of the purified protein, which also revealed the
CTD could be subdivided into the CTD-α (residues 310−355) and CTD-β (residues
356−486) (7). MeCP2 is an intrinsically disordered protein (IDP). When analyzed by
circular dichroism (CD), over 60% of the protein sequence was estimated to be disordered
(7, 9). Characterization of MeCP2 by hydrogen/deuterium exchange (H/DX) demonstrated
that the entire polypeptide chain exhibited very fast exchange kinetics indicative of a
disordered structure, with the exception of the MBD, which showed slower exchange
kinetics and was more structured (10). CD studies of the isolated NTD, ID, TRD, and CTD
confirmed that they lack stable secondary structure (9). The 3D structure of the isolated
MBD has been determined by NMR (11), and of the MBD bound to methylated DNA by
X-ray crystallography (12). Thus, while we have an atomic level insight into how MeCP2
recognizes methylated DNA, the extensive disorder present throughout the protein
sequence has prevented a rigorous understanding of how full length MeCP2 functions as a
structural unit. The importance of understanding the structure of full length MeCP2 is
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further underscored by the presence of RTT missense mutations in all five domains of the
protein (13).
Here we have characterized the structure and dynamics of full length MeCP2 using high
speed atomic force microscopy (HS-AFM) (14–16).

HS-AFM previously has been

employed to visualize myosin V walking on actin filaments (17), the structural changes of
F1-ATPase (18), and the conformational dynamics of the ClpB chaperone (19), and holds
great promise for determining the structure and motions of intrinsically disordered proteins
(20–22). Our HS-AFM analyses indicate that MeCP2 rapidly interconverts between many
different structures, one of which has the shape of a dumbbell. The two more ordered parts
of the dumbbell correspond to the MBD and CTD and are connected by the long flexible
intrinsically disordered ID/TRD. The rapid conformational sampling of MeCP2 visualized
by HS-AFM was not random, but rather was driven by transient intramolecular
MBD−CTD interactions. Weak interaction of the isolated MBD and CTD in solution was
documented by analytical ultracentrifugation and NMR. The MBD within the full length
protein was unstable, undergoing an unfolding/refolding transition that could be observed
and quantified by HS-AFM. The unfolding/refolding transition of the MBD was influenced
by MBD−CTD interactions and was differentially altered by four missense mutations that
cause RTT. Taken together our results provide novel insight into the structure and
dynamics of MeCP2 and their possible misregulation in RTT.

5.3

Materials and methods

Protein expression and purification
Full-length human MeCP2 isoform e2, MeCP2-GFP, MeCP2 R294X, MeCP2 lacking
amino acids 311‒328 or 370‒415 in the CTD, isolated MBD74-171, isolated CTD300-486,
CTD363-402 and full-length MeCP2 bearing RTT point mutations in the MBD (R106W,
R133C, F155S, T158M) were expressed in Escherichia coli and purified using the Intein
Mediated Purification with an Affinity Chitin-binding Tag (IMPACT) system followed by
Heparin column (New England Biolabs) using a modification of the protocol described
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previously (7). The MBD construct contained an added sequence, EFLEGSSC, on its Cterminal ends as a result of previously described cloning methods. Escherichia coli
BL21RP cells were transformed with the ptyb1 plasmid vectors containing MeCP2
constructs using heat shock. The clones with the best inducing expression were selected
for each construct and stored at −80°C. Bacteria were grown in lysogeny broth (LB) at
37°C to an optical density of 0.5 absorbance unit, induced with 0.4 mM isopropyl 1-thioD-galactopyranoside and incubated at 30°C for 2–3 h prior to harvest. Expression hosts
were pelleted in an Avanti J-26 XPI preparative centrifuge (Beckman Coulter) in a JLA8.100 rotor at 5,000 g for 10 min. Pellets were resuspended in wash buffer (25 mM Tris,
pH 7.5, 100 mM NaCl) and repelleted under the same conditions. Clean pellets were
resuspended in column buffer (25 mM Tris-HCl, pH 7.5, 500 mM NaCl) supplemented
with 0.5% Triton X-100, 0.2 mM PMSF, and Protease Inhibitor Mixture Set II and Set III
(Calbiochem), followed by two rounds of sonication, 90 s each, using a Branson Sonifier
450 with a large tip at 50% duty cycle and a power output of 7. The lysate was transferred
to Oakridge tubes and spun at 21,000 g for 25 min at 4°C in the preparative centrifuge in a
JA-17 rotor (Beckman Coulter). The supernatant was mixed with 7 ml chitin beads (New
England Biolabs) previously equilibrated in column buffer and incubated overnight at 4°C
on a rotator on a low revolution rate. Chitin beads with supernatant mixture was applied on
an empty chromatography column (Life Sciences), and supernatant was allowed to flow
through. The column was washed with five column volumes of column buffer followed by
five column volumes of column buffer containing 900 mM NaCl to remove bacterial DNA
non-specifically bound to MeCP2. The chitin beads were washed with an additional 5
column volumes of 500 mM NaCl column buffer and incubated with column buffer
containing freshly added 50 mM DTT for 72 hours to complete cleavage. Protein was
eluted from the chitin column with column buffer, diluted from 500 mM to 300 mM NaCl,
and loaded onto a HiTrap Heparin HP column (GE Healthcare) using HPLC. Proteins were
eluted from the heparin column via step gradient from 300 mM NaCl to 1 M NaCl buffer
using 100 mM NaCl steps in 25 mM Tris (pH 7.5), 10% glycerol background buffer. Peak
fractions were pooled and dialyzed into 10 mM Tris (pH 7.5), 10 mM NaCl, 2% glycerol
and 0.25 mM EDTA. The concentration of labeled protein was determined using a Pierce
BCA test (Thermo Scientific).
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For the samples subjected to analytical ultracentrifugation analysis, we used sitedirected mutagenesis to replace with alanines (MonoC) all native Cysteines but Cys412 in
the CTD (300−486) domain. Next, we expressed and purified the construct as described
above and labeled the protein with Alexa 488-maleimide (Molecular Probes). The excess
fluorophore was removed using HiTrap Desalting column (GE Healthcare). The
concentration of labeled protein was determined using a BCA test, ensuring the fluorophore
alone had no signal at 488 nm. The proteins were 90% clean as observed by SDS-PAGE,
imaged with Typhoon 9500.

HS-AFM imaging
The HS-AFM imaging of protein molecules was performed as described (23). A glass
sample stage (diameter, ~2 mm; height, ~2 mm) with a thin mica disc (1 mm in diameter
and 0.05 mm thick) glued onto the top by epoxy was attached onto the top of the Z-scanner
using a drop of nail polish. A freshly cleaved mica surface was prepared by removing the
top layers of mica using Scotch tape. Then, a drop (~2 μl) of each diluted sample (2–5 nM)
in Buffer A (2 mM MgCl2, 10 mM Tris-HCl, pH 7.5) was deposited onto the mica surface.
After incubation for ~3 minutes, the mica surface was rinsed with 20 μl of Buffer A to
remove unattached protein molecules. The sample stage was then immersed in a liquid cell
containing ~60 μl of Buffer A. The HS-AFM observation was performed in the tapping
mode using a laboratory built apparatus (23). The short cantilevers (BL-AC7DS-KU4)
were custom-made by Olympus (Tokyo, Japan); resonant frequency ~1 MHz in water,
quality factor ~2 in water, and spring constant 0.1−0.15 N/m. The cantilever’s free
oscillation amplitude A0 was set at 1−2 nm and set point amplitude As was set at ~0.9 × A0,
so that the loss of cantilever’s oscillation energy per tap was adjusted at 1−3 kBT on
average. The images were captured at a rate of 14.9 frames per sec (fps) or 10 fps for a
scan area of 125 × 125 nm2 with a pixel size of 80 × 80.
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Analysis of AFM images
To measure topographical parameters of MeCP2 constructs from AFM images, a pixelsearch software program was used (24). AFM images were first edited with a low-pass
filter to remove spike noises and next with a flatten filter to make the overall xy-plane flat.
The (X, Y, Z) coordinate of globular domains (MBD and CTD) in their folded states were
measured semi-automatically using the following procedures. First, we selected manually
the most probable highest point on each domain and several molecule-free positions in
close proximity to each domain. Second, each highest point (X, Y, Z) was automatically
determined by searching a 5 × 5 pixel area (~8 × 8 nm2) around the manually selected point.
The (X, Y, Z) coordinate of the end region of IDR1 was also measured semi-automatically
using the following procedure. First, we determined manually an end region of IDR1 and
chose several molecule-free positions in close proximity to the end region. Next, the pixel
search program automatically found a pixel position (X, Y) having the largest height value
Z, as described above. The heights of globular domains (HMBD and HCTD) and the end of
IDR1 (He) were obtained by subtracting respective average heights of the substrate surface
from the corresponding Z values. To measure the end-to-end distance of IDR1 (RIDR1), the
direct distance D between the N-terminal end and the highest point within the MBD was
measured. The value of RIDR1 was estimated as RIDR1 = D – HMBD/2 – He/2. Similarly, the
end-to-end distance of IDR2 (RIDR2) was estimated as RIDR2 = D – HMBD/2 – HCTD/2, where
D represents the direct distance between the highest points of MBD and CTD. The height
of IDR (HIDR) was obtained by subtracting the average height of the substrate surface from
the Z values at positions along the ridgeline of the IDR. Note that the entire IDR1 is fully
disordered judging from its height (0.4–0.5 nm). However, the CTD appeared to show
partial order-disorder transitions with a small height change, so that IDR2 contains a region
that is not fully disordered. Therefore, DIDR2 does not represent the length of a fully
disordered IDR.
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Transition rate determination
The mutants, R294X, F155S, and MeCP2-GFP, exhibited folding/unfolding transitions in
their MBD. The autocorrelations G(τ)s of their time-series data of HMBD were best fitted to
single-exponential functions. However, the decay constants λ of these G(τ)s is the sum of
respective rate constants of the low-to-high transition (kL→H = 1/τL) and high-to-low
transition (kH→L = 1/τH); τL and τH are the lifetimes of partially unfolded and well-folded
states, respectively. To determine the values of kL→H and kH→L, we used the two Gaussian
components of each HMBD frequency distributions that overlap in a medium height region.
The ratio kH→L/kL→H (or τL/τH) was estimated from the area ratio (AL/AH) of the
corresponding two Gaussian components, i.e., kH→L/kL→H (≡ τL/τH) = AL/AH. For the cases
of WT MeCP2 and d311‒328 and d370‒415 deletion mutants, their G(τ)s were best fitted
to double-exponential functions. The values of rate constants of the stable (S)-to-unstable
(U) (kS→U), U-to-S (kU→S), high-to-low (kH→L) and low-to-high (kL→H) state transitions
were estimated as described in Supplementary Text S1.

Molecular dynamics simulations
Three systems were set up for molecular dynamics simulations: (i) the MBD domain alone,
(ii) the MBD with the half the NTD domain (36 amino acids) and (iii) the MBD with the
full NTD domain. The sequences used for these three cases are as follows:
MBD (PDBid: 1QK9):
ASASPKQRRSIIRDRGPMYDDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGK
AFRSKVELIAYFEKVGDTSLDPNDFDFTVTGRGSGSGC
MBD with half NTD:
GKHEPVQPSAHHSAEPAEAGKAETSEGSGSAPAVPEASASPKQRRSIIRDRGPMY
DDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGKAFRSKVELIAYFEKVGDTS
LDPNDFDFTVTGRGSGSGC
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MBD with NTD:
MVAGMLGLREEKSEDQDLQGLKDKPLKFKKVKKDKKEEKEGKHEPVQPSAHH
SAEPAEAGKAETSEGSGSAPAVPEASASPKQRRSIIRDRGPMYDDPTLPEGWTRK
LKQRKSGRSAGKYDVYLINPQGKAFRSKVELIAYFEKVGDTSLDPNDFDFTVTG
RGSGSGC
The initial structure for the MBD was taken from the Protein Data Bank (PDBid: 1QK9)
and the residues for the NTD domain were generated using the CNS-SOLVE software (25).
The peptide was placed in a dodecahedral box in which the distance from the edges of the
box to every atom in the protein was at least 1 nm. The box was solvated with explicit
water and an excess ion concentration of 150 mM was added to reproduce physiological
conditions. The simulations were performed using GROMACS 2016.3 software (26) with
the TIP3P water model (27) and the Amber99SB*-ILDNP force field (28). The system was
energy minimized and equilibrated in the NVT (constant particle number, volume and
temperature) ensemble. Equilibration was followed by a production run in the NPT
(constant particle number, pressure and temperature) ensemble with a time step of 2 fs. The
particle-mesh Ewald method (29) was used with a cutoff of 1.2 nm. The temperature was
set to 310 K with the V-rescale algorithm (30) and pressure was kept at 1 atmospheric
pressure using the Parrinello-Rahman barostat (31). The MBD domain was simulated for
3 μs and the MBD with NTD systems for 1 μs. At least three separate sets of simulations
starting from different initial conditions were run to ensure that the results were
independent of the starting conformations.
A second set of systems was built for the case where the mica surface exists, using
configurations from each of the above proteins systems after the first 100 ns of simulation.
Each protein was placed in a cubic box with a minimum distance of 1 nm between its atoms
and the edges of the box. A surface of size of each of the boxes was generated and a charge
was added to the surface atoms to reproduce the experimental surface charge of –0.48
e/nm2. The surface structure was modeled using graphene structure to ensure
commensurability with periodic boundary conditions. The box was solvated with explicit
water and an excess ion concentration of 150 mM. The system was energy minimized and
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equilibrated with NVT dynamics. Equilibration was followed by a production run in the
NVT ensemble with a time step of 2 fs. The temperature was set to 310 K with the Vrescale algorithm. The systems were run for 1 μs and repeated as above.

Analytical ultracentrifugation
Sedimentation and diffusion transport in the ultracentrifugation cell are described by the
Lamm equation, which can be solved using adaptive finite element methods (32). Whole
boundary data obtained in SV experiments are fitted by linear combinations of such
solutions using advanced optimization routines (33−35) that are typically implemented on
a supercomputer (36). Sedimentation velocity experiments were performed using a
Beckman XL-A analytical ultracentrifuge equipped with the Aviv fluorescence detector
(37) at the Center for Analytical Ultracentrifugation of Macromolecular Assemblies at the
University of Texas Health Science Center at San Antonio, using an An60Ti 4-hole rotor
and standard 2-channel epon centerpieces with 1.2 cm pathlength (Beckman-Coulter). The
CTD was fluorescently labeled with Alexa 488. The MBD was not labeled. Samples were
prepared in 20 mM Tris-HCl, containing 100 mM NaCl, 0.5 mM EDTA, and 0.1 mM
PMSF. A titration was performed where a constant amount of labeled CTD (200 nM) was
mixed with 100, 200 and 400 μM of unlabeled MBD. The experiment was performed in a
4-hole An60Ti rotor, at 50,000 rpm, 20ºC, and fluorescence detection, collecting 964 scans
for each sample before reaching equilibrium (~22 hours). All data were analyzed with
UltraScan-III ver. 4.0, release 2655 (38). Hydrodynamic corrections for buffer density and
viscosity were estimated by UltraScan to be 1.0017 g/ml and 1.0046 cP. The partial specific
volumes of CTD (0.727 ml/g) and MBD (0.7252 ml/g) were estimated by UltraScan-III
based on their amino acid sequence analogous to methods outlined in Laue et al. (39).
SV data were analyzed according to the workflow described in (40). Optimization was
performed by 2-dimensional spectrum analysis (2DSA) (33) with simultaneous removal of
time- and radially-invariant noise contributions (41). After inspection of the 2DSA
solutions, a global genetic algorithm-Monte Carlo analysis was performed to quantify the
relative concentrations of free and complexed CTD (35), and to obtain a model that
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described all four titrations equally well. The calculations are computationally intensive
and are carried out on high-performance computing platforms (36). All calculations were
performed on the Lonestar cluster at the Texas Advanced Computing Center (TACC) at
the University of Texas at Austin or on XSEDE clusters at TACC (Jetstream, Stampede 2)
or the San Diego Supercomputing Center (Comet). Integral distributions of sedimentation
coefficients were evaluated with the enhanced van Holde–Weischet method (42) to
determine if shifts of sedimentation distributions occurred as a function of mass action.

NMR spectroscopy
The sub-domain of CTD, containing residues 363-402 (CTD2), was expressed in minimal
media in the presence of ammonium N15-chloride, purified as described above and
concentrated using Amicon Ultra 15 mL centrifugal filter (Millipore). 1H,15N heteronuclear
single quantum coherence (HSQC) spectra were collected on 15N-labeled MeCP2 CTD (aa
363−402) at 100 M, free and in the presence of MBD. Spectra were collected at 25C on
a 600 MHz Varian INOVA spectrometer equipped with a cryogenic probe. Data were
processed using NMRPipe.

5.4

Results

Visualization and characterization of full length MeCP2 and its dynamics by HSAFM
To determine the structural features of MeCP2, we first imaged full-length wild type (WT)
MeCP2 using HS-AFM (16). The HS-AFM images document the highly dynamic behavior
of MeCP2; we see rapid interconversion between ensembles of different structures,
including a typical dumbbell-like structure (Fig. 5.1B). In the dumbbell structure, two
intrinsically disordered regions (IDRs) mostly with a height of 0.4−0.5 nm (Fig. 5.1C) were
observed: a short IDR1 at one end and a longer IDR2 connecting the two more ordered
ends of the dumbbell. The two-dimensional end-to-end-distances of IDR1 (RIDR1) and
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IDR2 (RIDR2) were <RIDR1> = 12.5 ± 3.6 and <RIDR2> = 18.5 ± 8.0 nm (mean ± s.d.) (Fig.
5.1D). The broad distribution of RIDR2 values reflects the conformational distortions of the
IDR2 resulting from the high degree of flexibility of this long segment. The globule
between the IDR1 and IDR2 had a peak height of 1.4 nm in its height distribution (Fig.
5.1E), indicating it is well folded. Interestingly, this well folded globule itself is dynamic
and undergoes unfolding/refolding transitions over time (Figs. 5.1E and 5.2A). The ordered
region at the other end of MeCP2 had a height of 0.8 nm, indicating it is partially or
“loosely” folded (Fig. 5.1F). We next assigned the N- and C-terminal ends of the MeCP2
molecule. HS-AFM images of a construct with GFP fused at the C-terminal end of MeCP2
indicated that the GFP tag was at the opposite end from the well folded globule (Fig. 5.2B,
and Figs. S5.1 and S5.2A). In contrast, the TRD−CTD construct lacked the well folded
globule (Fig. 5.2C and Fig. S5.3). From these results we conclude that IDR1 is the NTD,
the well folded globule that undergoes folding/unfolding transitions is the MBD, IDR2 is
composed of the ID, TRD and possibly a part of the CTD-α, and the loosely folded region
is the CTD or CTD-β (see Fig. 5.2D). A summary of the HS-AFM results is shown in Fig.
5.2D.
The unfolding/folding transitions of the MBD within WT MeCP2 were further
characterized by calculating the autocorrelation function of time-series of MBD height data
(ACFMBD). Notably, it showed a two-exponential decay (Fig. 5.2C and Supplementary Text
S5.1), suggesting that MBD structural transitions are more complex than a simple
equilibrium between two states, as detailed below in the next section. To determine if
absorption onto mica influenced the observed folding/unfolding transition of the MBD,
atomistic molecular dynamics simulations (MD) both in solution and in the presence of a
surface (to model the HS-AFM experiments) were performed. Results indicated that the
solution structure of the MBD was not perturbed by the mica surface over the time scale
of the simulation (Fig. 5.2F and Supplementary Movie S5.1). This is consistent with
previous H/DX studies indicating that the MBD samples folded and unfolded states in
solution (8).
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Figure 5.1 Structural features of WT MeCP2. (A) Domain diagram. (B) Typical HSAFM images captured at 10 fps. (C) Height histograms for IDR1 (top) and IDR2
(bottom). (D) End-to-end distance histograms for IDR1 and IDR2. These distances
were also measured for images in which the MBD and CTD appeared clearly as
globules. (E) Height histogram of the globule locating between IDR1 and IDR2. This
globule was identified as the MBD, as shown in Fig. 5.2D. (F) Height histogram for
the loosely folded globule. This globule was identified as the CTD or a part of the
CTD, as shown in Fig. 5.2D.
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Figure 5.2 Domain identification and dynamic conformational changes of MBD in
WT MeCP2. (A) HS-AFM images captured at 10 fps showing transitions of MBD
between well folded (WF) and loosely folded (LF) conformations. (B) AFM image of
MeCP2−GFP fusion. (C) AFM image of TRD−CTD. Arrowheads point individual
molecules. (D) Schematic of MeCP2 dynamics. (E) ACFMBD in WT MeCP2 (dots) and
the best result of its fitting to a sum of two exponential functions (solid line) (see
Supplementary Text S1). (F) Root mean square fluctuations (RMSF) of MBD height
of three MeCP2-derived peptides in solution and in the presence of a surface, as
observed by molecular dynamics simulation. The systems include MBD, MBD plus
C-terminal half of NTD, and MBD plus NTD.

Intramolecular MBD−CTD interactions influence MeCP2 structural dynamics
Previous studies have shown that the intrinsic fluorescence intensity of MeCP2 due to
W104 in the MBD is affected by removal of the CTD, suggestive of MBD−CTD
interactions (43). To examine this question directly, we performed HS-AFM imaging of
the RTT nonsense mutant, R294X, lacking the CTD. Remarkably, the MBD of R294X
existed predominantly in the unfolded state (Fig. 5.3A, B), despite no mutations in the
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MBD. This behavior was reflected in its ACFMBD, which had a single-exponential decay
(Fig. 5.3C). These results suggest that MBD−CTD interactions occur within the full-length
MeCP2 in cis, shifting the MBD towards its well-folded conformation for a longer time.
Further support for this conclusion came from three HS-AFM observations: (i) some of the
HS-AFM images of full-length MeCP2 showed the MBD and CTD in contact to form a
compact structure (Fig. 5.3D), (ii) removal of residues 311−328 in the CTD-α largely
shifted the MBD equilibrium toward the unfolded state, and the equilibrium change was
moderate when residues 370−415 in the CTD-β were removed (Supplementary Fig. S5.4),
and (iii) the MeCP2-GFP fusion showed a MBD height distribution expected for the mostly
unfolded state (Supplementary Fig. S5.2B) and the ACFMBD with a single-exponential
decay (Supplementary Fig. S5.2C), indicating that the GFP-dependent immobilization of
MeCP2 on mica prevented MBD−CTD interactions.
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Figure 5.3 MBD–CTD interactions in cis and trans. (A) HS-AFM images of R294X
RTT mutant captured at 10 fps. (B) Height histogram for MBD in R294X RTT
mutant. The most probable fitting curve is shown with the solid black line. The red
lines represent the Gaussian components in double-Gaussian fitting. (C) ACFMBD in
R294X (dots) and the best result of its fitting to a single exponential function (solid
line). (D) HS-AFM images of WT MeCP2 showing transient MBD−CTD association
(at 8.3 s and 13.4 s). (E) Sedimentation coefficient distributions of CTD (red) and three
titration points with different concentrations of MBD (green, 100 µM; blue, 200 µM;
black, 400 µM). Inset: Integral distribution of sedimentation coefficient plot for the
same experiment. (F) Superimposed 1H,15N HSQC spectra of the uniformly 15Nlabeled CTD363-402 region in the absence (black) and presence of MBD (red).
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To determine if the MBD and CTD interact in solution as free domains, we purified the
isolated CTD and MBD and characterized mixtures of the two using analytical
ultracentrifugation (AUC) and NMR. The sedimentation coefficient distribution of the
fluorescently labeled CTD (~20 kD) increased progressively when the CTD was titrated
with increasing amount of unlabeled MBD (~10 kD), as would be expected for the
formation of a reversibly associating complex (Fig. 5.3E, inset) (44). Global genetic
algorithm analysis (33,38) of the same data fits all experimental concentrations
simultaneously and indicated that the free CTD (1.35S) was progressively converted to a
MBD−CTD complex (1.85S) with increasing amount of MBD (Fig. 5.3E and
Supplementary Fig. S5.5A). From the titration curves, the KD for the MBD−CTD
interaction was estimated to be 1.29 ± 0.66 mM (Supplementary Fig. S5.5B), although the
data were limited. To further test for MBD−CTD interactions in trans, we collected
heteronuclear single quantum coherence (HSQC) spectra of uniformly 1H,

15

N-labeled

CTD363-402 in the absence and presence of the MBD (Fig. 5.3F). The large chemical shift
changes of CTD363-402 in the presence of the MBD provided further evidence that the two
domains directly interact in solution. Furthermore, appearance of a number of resonances
downfield of 9 ppm in the 1H dimension revealed that the MBD−CTD interaction induces
partial CTD folding. Altogether, we conclude from the HS-AFM and solution-state studies
that weak MBD−CTD interactions occur in both cis and trans. The cis interaction is
facilitated by the highly flexible ID/TRD. The effective CTD concentration in the close
vicinity of the MBD was estimated to be ~50 μM from the end-to-end distance distribution
of the IDR2 (Fig. 5.1D and Supplementary Text S5.2). From this value and the estimated
KD of ~1.3 mM, the MBD in ~4% of MeCP2 molecules is bound to the CTD in the steady
state.
The ACFMBD of WT MeCP2 decayed with two rate constants, λS = 0.077 s-1 and λU = 3.77
s-1 (Fig. 5.2E), whereas the ACFMBD of the R294X RTT mutant showed a singleexponential decay with a rate constant of 3.50 s -1 (Fig. 5.3C), nearly identical to the value
of λU = 3.77 s-1. These results suggest that when not interacting with the CTD, the MBD is
in an unstable (U) state undergoing fast transitions between folded (high) and unfolded
(low) conformations (L ↔ H). The transient MBD−CTD interaction converts the MBD
from the U state to a stable (S) state (U → S). In the S state, the folded (high) conformation
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of the MBD is sustained even after the dissociation of CTD (i.e., structural plasticity), and
decays slowly to the U state (S → U). According to this model, the rate constants for L →
H, H → L, U → S, and S → U transitions in the WT were determined as kL→H = 0.45 s-1,
kH→L = 3.32 s-1, kU→S = 0.059 s-1, and kS→U = 0.018 s-1 (Supplementary Text S1 and Table
S1).

Aberrant dynamics of RTT mutant MBDs
We next determined whether the unfolding/refolding transition of the MBD was influenced
by RTT mutations in the MBD (Fig. 5.4). Unfolding/refolding of the WT MBD occurred
at the sub-second to a second time scale in the U state, while in the S state stabilized by
transient MBD−CTD interaction the well-folded conformation is sustained for the tens of
seconds time scale as described above. On average, in the WT the MBD occupied the well
folded (1.4 nm height) conformation ~80% of the time and the unfolded (0.8 nm height)
conformation about ~20% of the time (Fig. 5.1E). HS-AFM imaging of full-length MeCP2
bearing RTT point mutations in the MBD (R106W, R133C, F155S, and T158M) (Fig. 5.4)
revealed that abnormal MBD dynamics is a common feature of all RTT mutants analyzed,
although the nature of the defect was mutant-specific. The R133C and T158M mutants
behaved most similarly, showing predominantly lower MBD height distributions compared
to the WT MBD (Fig. 5.4C, D). This indicates that the MBDs of these two mutants spend
most of their time in the unfolded state, i.e., the mutations destabilize the well folded MBD
structure. The F155S mutant existed in two populations, an unfolded state and a misfolded
state with a peak height of only 1.0 nm (Fig. 5.4E, F and Supplementary Table S5.1). By
contrast, the R106W mutation stabilized the MBD in a well folded conformation as
indicated by the predominance of a MBD species with ~1.4 nm height (Fig. 5.4B). These
results argue that the inherent transitioning of the WT MBD between its well folded and
unfolded states (and stable and unstable states) is required for proper MeCP2 function, and
when compromised may contribute to RTT.
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Figure 5.4 Structural features of MBD and CTD in MeCP2 bearing RTT point
mutations in MBD, and their comparison to the WT. Left panels, typical HS-AFM
images captured at 10 fps (A) or 15 fps (B–E). Middle panels, MBD height histograms.
The black lines are most probable fitting curves, while the red lines (A, E) show
Gaussian components in double-Gaussian fitting. The black lines are most probable
fitting curves. Right panels, height histograms for C-terminal globule. (F) ACFMBD in
F155S (dots) and the best result of its fitting to a single component exponential
function (solid line). (G) NMR structure of MBD.
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5.5

Discussion

As expected from its intrinsically disordered nature, the conformation of MeCP2 is highly
dynamic. In its most elongated state MeCP2 resembles a dumbbell. The MBD and CTD
form the ends of the dumbbell and the long intervening ID/TRD is maximally extended
(Fig. 5.1B). In its most compact state, the MBD and CTD are in contact, and the ID/TRD
appears to be folded upon itself or interacting with other parts of the protein (Fig. 5.3D).
Collectively, our data indicate that the conformational motions of MeCP2 (i) result from
equilibration between the extended and compact structures, (ii) are driven by MBD−CTD
interactions, and (iii) are facilitated by the flexible, intrinsically disordered ID/TRD
segment. The MBD−CTD interaction is direct and not an artifact of MeCP2 being adsorbed
to the mica surface. Indeed, the isolated MBD and CTD interact when free in solution as
judged by analytical ultracentrifugation and NMR (Fig. 5.3E, F). Moreover, Ghosh et al.
(43) showed that removal of the CTD reduced the fluorescence emission maxima of W104
in the MBD, indicating changes in the local tryptophan environment upon CTD deletion
and implying that MBD−CTD interactions occur within MeCP2 under solution conditions
(43).
The MBD is the only MeCP2 domain with classical tertiary structure. The NMR and Xray structures of the MBD reported a three-stranded antiparallel β-sheet packed against an
11-residue α-helix (Fig. 5.4G) (11, 12). Extending from the C-terminal end of the α-helix
is a short 3-10 helix followed by an Asx-ST motif. The first and second β-strands are
connected by an elongated nine residue loop that fits in the major groove of DNA (12).
Our HS-AFM experiments have revealed that the MBD transitions between its well folded
conformation and an unfolded state, indicating that the MBD within full length MeCP2 is
only marginally stable. These results are in close agreement with previous H/DX analyses
of full length MeCP2 in solution. Whereas a stably folded protein exhibits slow exchange
kinetics, a moderate level of exchange occurred throughout the MBD (10), demonstrating
that the MBD samples unfolded and folded states. The R106W, R133C, F155S, and T158M
RTT mutants each affected the MBD folding/unfolding equilibrium, although in different
ways. The R133C and T158M mutants greatly destabilized the folded state of the MBD
(Fig. 5.4C, D). The chief characteristic of the F155S mutant was that the MBD was
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misfolded and more unstable (Fig. 5.4E). All three of these mutations are located in
positions that would be expected to disrupt proper folding of the MBD (Fig. 5.4G).
Strikingly, the stability of the MBD was enhanced by the R106W mutation, such that the
unfolded state of the MBD could only rarely be detected in this mutant (Fig. 5.4B). When
analyzed by H/DX, the isolated MBD bearing the R106W mutation showed very similar
exchange kinetics as wild type except for increased protection of the residues in the β1
strand surrounding the mutation (10). These observations suggest that the β-sheet found in
the MBD is stabilized by the R106W mutation (Fig. 5.4G), perhaps through gain of pi-pi
interaction with W104, resulting in a decreased propensity of the MBD to unfold. Taken
together, our results imply that misregulation of the MBD unfolding/folding transition—in
either direction—may contribute to RTT.
The unfolding/refolding transition of the MBD appears to be integral to the mechanism of
MeCP2 binding to unmethylated and methylated DNA. In the H/DX experiments
performed with full length WT MeCP2, the protection observed throughout the MBD was
enhanced by DNA binding and enhanced further by methylated DNA binding (10). This
would be expected if the MBD was transitioning between unfolded and folded states and
binding to DNA and methylated DNA sequentially stabilized the folded conformation. This
observation is consistent with the results of Ghosh et al. (43), who found that binding to
unmethylated and methylated DNA successively increased the Tm of MeCP2 in thermal
melting experiments. Despite having a stable well folded structure (Fig. 5.4B) that is almost
identical to wild type (10), the R106W mutant does not bind normally to either
unmethylated or methylated DNA in vitro (43, 45), is not retained in chromatin in vivo
(46), and has a severe RTT phenotype (43) consistent with disrupted MBD function. These
results are difficult to reconcile with a classical one-step mechanism of protein-DNA
recognition mediated by a stable DNA binding domain. At the same time, the R133C,
F155S, and T158M mutations all destabilize the well folded MBD state (Figs. 5.4C−E),
and all show impaired binding to methylated DNA (43, 45), indicating the importance of
the MBD fold for methylated DNA recognition. One possible explanation is that the MBD
initially engages with DNA when it is unfolded and subsequently assumes the MBD fold
to create a stable complex with methylated DNA. We note that the properties of the RTT
mutants identified in our studies have implications for disease treatment. Based on the HS-
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AFM behavior of the RTT mutants, small molecules that stabilize the MBD fold may prove
useful for treating patients with the R133C, F155S, and T158M mutations, while patients
with the R106W mutation may benefit from small molecules that destabilize the MBD.
The inter-domain interactions of MeCP2 are likely to be functionally important. MeCP2
condenses chromatin fibers into unique higher order structures characterized by edge-toedge clustering of neighboring nucleosomes (47), although how it accomplishes this is
unknown. Both the MBD and CTD bind to DNA and nucleosomes (48). We therefore
speculate that the MBD and CTD bind to different nucleosomes when in the extended
MeCP2 conformation, and subsequent MBD−CTD interactions help bring the nucleosomes
together to condense the fiber. The plasticity observed in our experiments (Supplementary
Text S5.1) may help stabilize such structures once formed. MeCP2 recruits the
transcription factors to methylated DNA in vivo (49). The interaction sites for some of
these factors, such as transcription co-repression complex NCoR, are located near the
TRD−CTD boundary (50). In these cases, the transcription factors will be brought into
physical proximity with methylated DNA upon MBD−CTD contact. If the MBD and CTD
in the extended MeCP2 conformation bind to two linearly distant genomic loci that are in
close proximity in three dimensions, MBD−CTD interactions and recruitment of the
CCCTC-binding transcription factor, CTCF (51), may facilitate formation of chromatin
loops. Taken together, the function of MeCP2 in transcription factor recruitment may
involve more than a simple tethering process. In a broader sense, we speculate that the
conformational dynamics of MeCP2 provides the structural basis for its multifunctionality. We note that the situation in which two structured domains are separated by
a long intrinsically disordered region is predicted to be common among IDPs (51).
Consequently, it seems likely that the intramolecular domain-domain interactions observed
in our studies may be shared by many disordered proteins. We postulate that
conformational malleability driven by domain-domain interactions in cis and structural
flexibility of the intervening polypeptide chain is a common feature of many IDPs and is
essential for mediating their functionality in three dimensions.
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5.6

Supplemental information

The pixel-search program for AFM images can be accessed at the following URL:
https://elifesciences.org/content/4/e04806/article-data#fig-data-supplementary-material

Movies from the molecular dynamics simulations can be accessed at the following URL:
https://doi.org/10.5281/zenodo.5774094

S5.1. Analysis of folding/unfolding dynamics of MBD
The state transitions of MBD contained in the WT MeCP2 are considered to take place
according to the model shown below:

The transition from the unstable (U) state to the stable (S) state is triggered by transient
interactions between the MBD and the CTD, whereas the transition from S to U state takes
place autonomically. The U state is in dynamic equilibrium between the unfolded state
(low state L) and the well-folded state (high state H). In the S state, the MBD is well folded
and its height is identical to that in the H state (1.4 nm). The time course of MBD height
variations and state transitions are schematized below.
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Let’s define NU as an average number of transitions (L ↔ H) occurring during the single
U state. The following relationship holds:
1/kU→S (lifetime of U state) = NU × (1/kL→H + 1/kH→L).

(S1)

Eq.(S1) can be rewritten as
NU = kL→H × kH→L / [kU→S × (kL→H + kH→L)].

(S2)

The total time during which the MBD assumes the unfolded (low) conformation in the
single U state (TL) is identical to NU/kL→H on average, while the total time during which
the MBD assumes the well-folded (H) conformation in the single U and S states (TH) is
NU/kH→L + 1/kS→U on average.
The area ratio (αWT ≡ AL/AH = 0.24) of two Gaussian components of MBD height
distribution in WT MeCP2 (Fig. 5.1E in the main text) is identical to TL/TH. Therefore, we
obtain
αWT = (NU/kL→H) / (NU/kH→L + 1/kS→U) =
kS→U × (kH→L/kL→H) / [kU→S + kS→U + kU→S × (kH→L/kL→H)].

(S3)

For the case of WT MeCP2, the autocorrelation function of time-series of MBD height data
(Fig. 5.2D in the main text) was best fitted to the sum of two exponential functions, A ×
Exp(−λSt) + B × Exp(−λUt), from which we obtained the values of λS = 0.077 s−1 and λU =
3.77 s−1. Since the two different transitions, L ↔ H in the U state and U ↔ S, take place
independently, the autocorrelation function of this kinetic system is expressed as a sum of
two exponential functions, consistent with the above result. The decay rates in the
autocorrelation function, λS and λU, are therefore, expressed as
λS = kU→S + kS→U

(S4)
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and
λU = kL→H + kH→L.

(S5)

The conformational transitions L ↔ H in the U state of the WT MeCP2 are considered to
be identical to those occurring in the MBD contained in R294X, because R294X lacks the
CTD and thus its MBD always stays in the U state. In fact, its autocorrelation function of
time-series of MBD height data showed a single-exponential decay (Fig. 5.3C in the main
text). Moreover, its decay rate (λU = 3.50 s−1) was close to the value, λU = 3.77 s−1, estimated
for the WT MeCP2. Therefore, the lifetime ratio [τL/τH = kH→L/kL→H] in the U state of MBD
in WT MeCP2 can be approximately obtained from the area ratio (α294X ≡ AL/AH = 7.43) of
two Gaussian components of the MBD height distribution in R294X (Fig.5.3B in the main
text), i.e.,
kH→L/kL→H = α294X.

(S6)

Thus, kL→H and kH→L are expressed as
𝜆

𝑘L→H = 1+𝛼U

294X

,

(S7)

and
𝑘H→L =

𝛼294X ∙𝜆U
1+𝛼294X

.

(S8)

From Eqs.(S3), (S4), and (S6), we finally obtained the following relationships for kU→S and
kS→U in the WT MeCP2:
(𝛼294X − 𝛼WT )

𝑘U→S = 𝜆s ∙ 𝛼

294X (1+𝛼WT )

,

(S9)

.

(S10)

and
𝛼

𝑘S→U = 𝜆s ∙ 𝛼WT

(1+𝛼294X )

294X (1+𝛼WT )
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Using these equations and the values of λS = 0.077 s−1, λU = 3.77 s−1, αWT = 0.25, and α294X
= 7.43, we obtained kU→S = 0.059 s−1 (τU = 16.9 s), kS→U = 0.018 s−1 (τS = 55.6 s), kL→H =
0.45 s−1 (τL = 2.22 s), and kH→L = 3.32 s−1 (τH = 0.30 s) for the MBD in WT MeCP2. For
R294X, we obtained kL→H = 0.42 s−1 (τL = 2.38 s), and kH→L = 3.09 s−1 (τH = 0.32 s).
In the MeCP2−GFP fusion, the GFP moiety is firmly attached to the mica surface, which
largely suppresses Brownian motion of CTD on mica. Therefore, MBD−CTD interactions
are hampered. In fact, the MDB height distribution in this construct (Fig. S5.2B) was
similar to that of R294X (Fig. 5.3B in the main text), and the area ratio (αGFP ≡ AL/AH) was
10.24. The autocorrelation function of time-series of MBD height variations in the
MeCP2−GFP fusion was best fitted to a single exponential function with a decay rate of
λU = 3.08 s−1 (Fig. S5.2C). From these results and Eqs. (S7) and (S8), we obtained kL→H =
0.27 s−1 and kH→L = 2.81 s−1, which are roughly identical to the corresponding values
estimated for R294X. Similarly, we obtained the values of rate constants for d311−328,
d370−415, and F155S. These results are summarized in Supplementary Table S5.1.

S5.2. Effective concentration of CTD around MBD
The MBD and CTD are linked with the highly flexible IDR2 chain. Therefore, the effective
concentration (Ceff) of the CTD around the MBD must be high. We here estimate the value
of Ceff, as shown below.

1. The first approximation
We assume that IDR2 encompasses residues 164−309 (ID/TRD), although it may also
contain a part of the CTD-α. From the number of residues contained in the ID/TRD, Naa =
146, the stretched IDR2 length (contour length) is estimated to be L = 52.6 nm, using the
relationship of L = (Naa – 1) × daa, where daa (= 0.36 nm) is an average distance between
adjacent residues. In this first approximation, we further assume that the IDR2 is extremely
flexible, so that the probability of finding the CTD is nearly uniform over the spherical
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space of radius L, centered at the MBD. The effective concentration Ceff can be simply
calculated as
4𝜋

𝐶eff = 10−3 /( 3 𝐿3 ∙ 𝑁A ),

(S11)

where NA is the Avogadro constant. Here we neglected the dimensions of MBD and CTD,
as they are much smaller than L. Eq. (S11) gives Ceff ≈ 2.7 μM for L = 52.6 nm.
2. The second approximation
In reality, the CTD is not uniformly distributed around the MBD. In fact, the twodimensional distance RIDR2 between the two globular domains (MBD and CTD) showed a
Gaussian distribution with a peak at 18.5 nm (i.e., mean RIDR2, <RIDR2>), ~3-times shorter
than the full-stretched length L. Supposing that IDR2 is neither extended nor compacted
by contact with the mica surface, the mean end-to-end distance of IDR2 in solution (i.e.,
not on mica) is given by <R> = <RIDR2>/√2 = 13.08 nm. However, our measurements of
two-dimensional end-to-end distances <R2D> for various fully disordered IDRs have
indicated that mica–IDR interactions extend <R2D> by a factor 1.24. This is due to frictional
forces locally exerted from mica against fast Brownian motion of the IDR chain, which
would increase the IDR chain’s undulation wavelength and/or decrease the undulation
amplitude, resulting in swelling of its two-dimensional dimensions [Kirk, J. and Ilg, P.
(2017) Chain dynamics in polymer melts at flat surfaces. Macromolecules, 50,
3703−3718]. Therefore, <R> is estimated to be 13.08/1.24 = 10.55 nm. An fully disordered
IDR is considered to behave as an ideal Gaussian chain. In this case, the distribution
function of R is given by
3

3/2

𝑃(𝑅)𝑑𝑅 = 4𝜋𝑅2 [2𝜋〈𝑅2 〉]

3 𝑅2

𝑒𝑥𝑝 [− 2 〈𝑅2 〉] 𝑑𝑅,

(S12)

although an region in IDR2 close to (or contained in) the CTD-α may not be fully
disordered. The two globular domains associate with each other when they approach within
a certain range of distance, (r ≤ r0). However, the distance r between the two domains is a
complex function of R, when we consider the actual dimensions of the two globules. To
avoid this complexity, we assume that MBD–CTD association occurs when R becomes R0
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or shorter (i.e., R ≤ R0). In this approximation, the probability of finding the CTD in the
volume (R ≤ R0) is given by
𝑅

𝑝 = ∫0 0 𝑃(𝑅)𝑑𝑅.

(S13)

Therefore, the effective concentration of the CTD in the volume in close proximity to the
MBD is given as
4𝜋

𝐶eff = 𝑝 × 10−3 /( 3 𝑅03 ∙ 𝑁A ).

(S14)

For R0 = 1 nm, Eq.(S13) provides p = 0.32 × 10−3, and Eq.(S14) provides Ceff ≈ 120 μM.
Note that Ceff (R0) slowly decays with increasing R0. Therefore, the approximate value of
~120 μM holds for the range of 0 < R0 < 2.0 nm. When we consider the actual dimensions
of the two globules, the value of Ceff is reduced. Since the CTD binding site on the MBD
is localized at its certain surface area, the CTD available for MBD binding is reduced
approximately to a half. Therefore, the likely value of Ceff is approximately ~50 μM.
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Figure S5.1 Domain diagrams of wild type MeCP2 and its mutants used in this study.

130

Figure S5.2 Structural features of MeCP2 fused to GFT at the C-terminus of the
former. (A) Typical HS-AFM images captured at 15 fps (top). The images (bottom)
were obtained by increasing the brightness contrast on the corresponding images
(top). (B) MBD height histogram. Note that the MBD is mostly in the lower (unfolded)
state, in contrast to the case of WT MeCP2. (C), Autocorrelation function of MBD
height variation over time. The best result of its fitting to a single exponential function
is shown in the solid line (also see Supplementary Text S1).
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Figure S5.3 Structural features of TRD–CTD. (A) Typical HS-AFM images captured
at 15 fps. Four individual molecules are marked with arrow heads with different
colors. (B) Height histogram for highest pixel positions in the molecules.
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Figure S5.4 Structural features of d311−328 and d370−415 mutants and their
comparison to the wild type. (A−C), Typical HS-AFM images captured at 10 fps.
(D−F), Height histograms for MBD and CTD, and Autocorrelation functions of MBD
height variations over time. (G), Schematic showing MBD structure stabilization by
interaction between MBD and residues 311−328.
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Figure S5.5 Analysis of ultracentrifugation data. (A) Two-dimensional representation
of the global genetic algorithm Monte Carlo analysis. Solutes are represented by
colored spots, whose color intensity is proportional to their concentration. The
position of the spots indicates their approximate buoyant molar masses and their
anisotropies. An isotropic particle has an anisotropy of one, higher values indicate
increasingly non-globular structure. An anisotropy of 2 or higher indicates
significantly elongated shape in solution. Molar masses are approximate since partial
specific volumes used to transform sedimentation and diffusion coefficients for each
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species are only estimated. Additional uncertainty is present for the low concentration
complex because only a small amount of signal is available. (B) Estimation of Kd value
for the CTD−MBD complex. A limited number of data points were available for the
fit of the binding isotherm, producing a relatively large error in the estimate.

Table S5.1 Decay rates of auto-correlation functions calculated from time-series of
MBD height data and rate constants for structural transition dynamics of MBD.

All values are of mean ± s.e.

Other supplementary materials for this manuscript include the followings:
Movie S5.1. Four movies from molecular dynamics simulations of MBD and half NTD
domain (top) and MBD and the full NTD domain (bottom). Systems in the presence of a
surface are shown on the left-hand side and systems in solution are on the right. The
simulations were performed in explicit water but water has been removed from the movies
for clarity. Importantly, the structures in the systems remain the same both in the presence
and absence of the surface. The movies are from the end of independent 1 μs simulations.
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6.1

Abstract

The malfunction of the Methyl CpG binding protein 2 (MeCP2) is associated to the Rett
syndrome, one of the most common causes of cognitive impairment in females. MeCP2 is
an intrinsically disordered protein (IDP), making its experimental characterization a
challenge. There is currently no structure available for the full-length MeCP2 in any of the
databases, and only the structure of its MBD domain has been solved. We used this
structure to build a full-length model of MeCP2 by completing the rest of the protein via
ab initio modelling. Using a combination of all-atom and coarse-grained simulations, we
characterized its structure and dynamics as well as the conformational space sampled by
the ID and TRD domains in the absence of the rest of the protein. The present work is the
first computational study of the full-length protein. Two main conformations were sampled
in the coarse-grained simulations: a globular structure similar to the one observed in the
all-atom force field and a two-globule conformation. Our all-atom model is in good
agreement with the available experimental data, predicting amino acid W104 to be buried,
amino acids R111 and R133 to be solvent accessible, and having 4.1% of α-helix content,
compared to the 4% found experimentally. Finally, we compared the model predicted by
AlphaFold to our Modeller model. The model was not stable in water and underwent
further folding. Together, these simulations provide a detailed (if perhaps incomplete)
conformational ensemble of the full-length MeCP2, which is compatible with experimental
data and can be the basis of further studies, e.g., on mutants of the protein or its interactions
with its biological partners.

6.2

Introduction

Methyl CpG binding protein 2 (MeCP2) is a transcriptional regulator essential for growth
and synaptic activity of neurons1. The malfunction of this protein is associated to the Rett
syndrome, one of the most common causes of cognitive impairment in females 2,3. The
MeCP2 gene is X-linked in mammals. Mutations that affect the protein function were
initially thought to be lethal in males4, but these are now frequently identified in cognitively
impaired male patients5.
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MeCP2 is an intrinsically disordered protein (IDP), and little is known about its molecular
architecture during normal cellular processes and in disease6. IDPs are characterized by a
low proportion of bulky hydrophobic amino acids and high proportions of charged and
hydrophilic amino acids. Consequently, they cannot bury sufficient hydrophobic core to
fold spontaneously into stable, highly organized three-dimensional structures; instead, they
fluctuate through an ensemble of conformations7. The physical characteristics of IDPs
makes their structural characterization a challenge as these proteins are more sensitive to
degradation.
MeCP2 contains 486 amino acids, is a monomer in solution and is composed of six
different domains8. Residues 78-162 specifically bind to methylated CpG dinucleotides
and have been termed the methyl-CpG binding domain (MBD)9. Another functionally
annotated region corresponds to the transcriptional repression domain (TRD) whose main
function is to repress the transcription of genes10. Biophysical and protease digestion
experiments identified three other domains: the N-terminal domain (NTD), the intervening
domain (ID) and the C-terminal domain (CTD), which can be subdivided into CTD-α and
CTD-β8 (Fig. 6.1).

Figure 6.1 MeCP2 is composed of six domains: The N-terminal domain (NTD), the
methyl-CpG binding domain (MBD), the intervening domain (ID), the transcription
repression domain (TRD) and the C-terminal domain (CTD) which can be subdivided
into CTD-α and CTD-β. The only available structure1 contains solely the MBD
domain, which is the only ordered region in the protein.

There is currently no structure available for the full-length MeCP2 in any of the protein
databases. MBD is the only domain for which the secondary structure is known, and it only
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accounts for ~17% of the amino acids1 ; MBD is also the only ordered domain. Circular
dichroism (CD) of recombinant human MeCP2 has shown that the protein consists of ~35%
β-strand/turn, 5% α-helix and almost 60% is unstructured2. Characterization of MeCP2 by
hydrogen/deuterium exchange has indicated disorder in the entire polypeptide chain with
the exception of the MBD domain3. Further CD studies of isolated NTD, ID, TRD and
CTD domains confirmed their lack of stable secondary structure 4. It has been
experimentally demonstrated that the NTD, CTD and TRD domains can undergo a coil to
helix transition, with the TRD showing the greatest tendency for helix formation4.
To date, two computational studies of MeCP2 have been reported, and both focus on the
ordered MBD domain only. Kucukkal and Alexov reported comparative MD simulations
of the R133C mutant and wild-type MBD5, and Yang et al. studied the effects of Rett
syndrome-causing mutations on the binding affinity of MBD to CpG dinucleotides6. The
scarcity of computational studies is due to the lack of a three-dimensional structure of the
full-length protein. Nevertheless, computer simulations have been able to predict the
structures of IDPs. For example, using a coarse-grained model, ab initio simulations of
pKID successfully modeled its coupled folding and binding to KIX7, and a combination of
homology and ab initio modelling provided valuable insight into the three-dimensional
structures of intrinsically disordered e7 proteins8. In this work, we used the known structure
for the MBD domain as a starting point with the rest of the protein built by ab initio
modeling. Using a combination of all-atom and coarse-grained simulations, the folding of
the full-length MeCP2 and the conformational ensemble it could sample were studied.

6.3

Materials and methods

Ab initio modelling
Modeller9 version 9.19 was used to build a model for the full-length MeCP2 protein. Using
the BLAST algorithm10, we searched the UniProt database11 for homologues of MeCP2
with a 3D structure. Unfortunately, the only known structures belong to homologues of the
MBD domain, which accounts for only ~17% of MeCP2 amino acids and whose structure
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has already been determined. Thus, we used the Protein Data Bank 1QK9, 1 which contains
the MBD domain structure, as a template. Twenty different models were generated with
Modeller9. There was little variation between the different models and thus the first model
was chosen as the starting structure for the simulations (Fig. S6.1). With the aim of having
a different starting structure for our coarse-grained simulations, a second model was built
by refining the loops of the first model using the loopmodel class in Modeller. There is no
structural information on this protein besides its known disorder and the structure of the
MBD domain, and thus no quality assessment predictors were used to evaluate the
generated models. The evaluation will come from the data obtained during the simulations.
The AlphaFold12 model for human MeCP2 (UniProt code: P51608) was downloaded from
the database hosted by the European Bioinformatics Institute (https://alphafold.ebi.ac.uk).
Three simulations were performed with this model as the initial structure, using the
procedure described in the next section.

All-atom simulations
The following procedure was used in all of the all-atom MD simulations: The initial
structure was placed in a dodecahedral box in which the distance from the edges of the box
to every atom in the protein was at least 1 nm. The box was solvated with water and 150
mM of NaCl was added to reproduce physiological conditions. Counterions were added to
maintain the overall charge neutrality of the system. Simulations were performed using
GROMACS 2016.313 with the TIP3P water model14 and the Amber99SB*-ILDNP force
field15. The only exception is the set of five replicas for the ID and TRD domains that were
run with the CHARMM36IDPSFF force field that is parameterized specifically for
intrinsically disordered proteins16. This IDPs-specific force field has been shown to
produce good results when compared to other force fields in a recent study of amyloid-β17,
an extensively studied IDP. Table S6.1 contains the details of the all-atom simulations:
three simulations of Modeller models, three simulations of the AlphaFold model and 12
simulations of sections of the ID and TRD domains of different lengths.
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Each system was first energy minimized using the method of steepest descents and preequilibrated in the canonical ensemble, i.e., at constant particle number, temperature and
volume, for 100 ps. Pre-equilibration was followed by a production run with a time step of
2 fs. The Lennard-Jones potential was truncated using a shift function between 1.0 and 1.2
nm. Electrostatic interactions were calculated using the particle-mesh Ewald method
(PME)18,19 with a real space cut-off of 1.2 nm. The temperature was set to 310 K with the
V-rescale algorithm20 and pressure was kept at 1 atm using the Parrinello-Rahman
barostat21. Bonds involving hydrogens were constrained using the Parallel Linear
Constraint Solver (P-LINCS) algorithm22.
Some systems (marked as “resized” in Table S6.1) were moved into a smaller simulation
box after an initial run in which the protein became more compact. The final configuration
of the initial simulation was placed into a new simulation box in which the distance from
the edges of the box to every atom in the protein was again at least 1 nm. The new box was
solvated with water, 150mM of NaCl and counterions. Each new system was energy
minimized and pre-equilibrated in the canonical ensemble before moving to the production
run. All parameters mentioned above were kept the same. Trajectory analysis was
performed using Gromacs built-in tools13 and MDAnalysis23,24.

Coarse-grained simulations
The intermediate-resolution implicit solvent coarse-grained protein model PLUM25 by
Bereau and Deserno was used to further explore the conformational landscape of MeCP2.
This model represents the backbone with near-atomistic resolution, with beads for the
amide group N, central carbon Cα and carbonyl group C’. The side chains are represented
by single beads located at the first carbon Cβ of the all-atom model. The N and C’ beads
can hydrogen bond through a directional potential which depends on the implicit positions
of hydrogen and oxygen atoms within them. The PLUM model has been successfully used
to study a variety of scenarios such as the aggregation of polyglutamine 26, β-barrel
formation at the interface between virus capsid proteins27, folding of transmembrane
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peptides28, and it has been shown to be able to reproduce the secondary structure of small
IDPs involved in biomineralization29.
Simulations using this model were carried out in GROMACS 4.5.513 specifically modified
to support the PLUM model. All interaction parameters were taken from the original work
of Bereau and Deserno25. The simulations were run in the canonical ensemble (NVT) with
a Langevin thermostat with friction constant 𝛤 = 𝜏 −1 and an integration timestep of 𝛿𝑡 =
0.01𝜏, where τ is the natural time unit in the simulation. The reduction in degrees of
freedom removes friction and speeds up the motion through phase space and thus this time
unit is not equivalent to the time step in an all-atom simulation25. Table S2 contains the
simulation details.

6.4

Results

The all-atom protein is largely unstructured
A full-length MeCP2 all-atom protein model, henceforth referred to as MeCP2_1, was
simulated for 1,550 ns. The protein started with an extended conformation (Fig. 6.2) in
order to minimize bias towards any particular fold. After an initial simulation of 150 ns,
the protein had become more compact and it was moved to a smaller box to increase
efficiency. Figure 6.2 shows a drastic decrease in the radius of gyration (Rg) during the first
20 ns of the simulation, when it went from 8.35 nm to 4.56 nm. Although R g continued to
fluctuate, it never surpassed 5 nm. Moving the protein to a smaller box allowed a reduction
in the number of water molecules from ~793,000 to ~120,000 (Table S6.1).
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Figure 6.2 Radius of gyration (Rg) of the full-length MeCP2 in the initial simulation
box. The protein becomes more compact during the first 20 ns. The inset shows the
initial structure. MBD, the only ordered domain, is clearly visible.

The protein was then run in the new box for an additional 1,400 ns. The protein remained
highly flexible; its root-mean-square deviation (RMSD) from the initial structure continued
to show small fluctuations throughout the trajectory, as expected for an IDP (Fig. 6.3A).
The most populated cluster in the last 400 ns of the simulation is largely unstructured with
only small motifs of secondary structure (Fig. 6.3B). Shown in Fig. 6.3B red are the
residues with a root mean square fluctuation (RMSF) larger than 0.6 nm. Figure 6.3C
shows the RMSF of each amino acid throughout the last 400 ns of the trajectory. The
residues with the highest RMSF are located in the NTD and CTD-β domains, at the
opposite ends of the protein, and in two solvent-exposed loops.
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Figure 6.3 All-atom MD simulation of the full-length MeCP2. A) RMSD of the protein
in the smaller simulation box. B) Most sampled cluster throughout the last 400 ns of
the simulation. Red: residues with an RMSF higher than 0.6 nm. C) RMSF of the
protein throughout the last 400 ns of the simulation. The different domains are
marked following the color code in Fig 1.

The last 400 ns of the 1,400 ns trajectory were clustered using the method of Daura et al.30
with a 0.5 nm cut-off. The secondary structure was computed for the most representative
structure in each of the 11 clusters obtained (Table S6.3). The weighted averages show that
20 residues had an α-helix conformation (4.1%), 113 residues were in β-strands or turns
(23.2%) and 338 residues were in random coil (69.7%). This is very similar to experimental
data of Adams et al., in particular the amount of α-helix compared to the experimentally
(by CD) determined 4%31.
We also computed the secondary structure of the protein throughout the last 400 ns of the
simulation using DSSP32,33. The secondary structure elements in the MBD domain are very
stable, appearing in at least 80% of all frames (Fig. 6.4). Adams et al31 reported the
secondary structure for the MBD domain on its own to be 10% α-helix, 51% β-strands or
turns and 38% unstructured, and the NMR structure (PDBid: 1QK91) contains 12% α-helix,
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20% β-strands or turns and is 69% unstructured. The MBD domain in our simulation had
15% α-helix, 28% β-strands or turns, and is 57% unstructured. Overall, our simulation is
in good agreement with the experimental data. The most disordered domains are the ID
domain (Fig. S6.4) and the CTDα domain (Fig. S6.6). The NTD domain has two short βstrands and two helices, with one of them present in 60% of the simulation frames (Fig.
S6.3). The TRD domain formed a helix in residues 241 to 244 in 70% of the simulation
and two β-strands were observed in 6% of the frames (Fig. S6.5). The residues in the αhelix correspond to 4% of the TRD residues and the unstructured residues to 87% of the
TRD amino acids. This is in good agreement with the 3% of α-helix and 85% of
unstructured residues measured by Adams et al31. Five helices are observed in the CTDβ
domain, with two of them present 80% of the simulation (Fig. S6.7).
Even though some of the secondary structure elements appeared in only a small fraction of
the frames, these could become stable upon interaction with another protein, DNA or a
small molecule. In fact, most domains in MeCP2 can bind to DNA; the MBD domain binds
to symmetrically methylated 5′CpG3′ pairs with a preference for A/T-rich motifs34,35, an
autonomous DNA binding domain has been identified in the ID domain36, the TRD domain
possesses a non-specific DNA binding site31,36 and there is a distinct non-specific binding
site for unmethylated DNA in the CTDα domain36.

Percentage

coil
bend
turn
strand
heli
bridge

2
2

2

Residue number

Figure 6.4 Percentage of frames in the last 400 ns of the MBD domain with every type
of secondary structure. The secondary structure of the MBD domain observed in the
MeCP2_1 simulation, 15% α-helix, 28% β-strands or turns, and 57% unstructured,
is in good agreement with experimental data31.
Principal component analysis (PCA) of the trajectory underlines the structural
rearrangements that the protein undergoes during the first 600 ns of the simulation (Fig.
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S6.8A). After this time, the protein explores a much smaller portion of the conformational
space. In contrast, the TRD domain begins to sample more conformational space in the
second half of the simulation (Fig. S6.8B).
The experiments by Ghosh et al.37 showed that the single tryptophan of MeCP2, which is
located at position 104 in the MBD domain, is strongly protected from the aqueous
environment. Using the STRIDE web server38, we computed the relative solvent accessible
surface area (rSA) of residue W104 in the four most populated clusters (Table S6.4). The
first four clusters contain 98% of all frames in the last 400 ns simulation. Although there
is no consensus on where to set the threshold to determine if an amino acid is buried, it is
typically set between 10% and 20%39,40. The weighted average for the four clusters gave a
rSA of 8.1% and thus it can be considered to be buried inside the protein, in agreement
with the experimental data.37
R133C is one of the most common disease-causing mutations in the MBD domain37. The
x-ray structure of an MBD-DNA complex has revealed that Arg 133 is involved in the
DNA interaction surface41, and the study by Lei et al.42 found that this residue, together
with Arg 111, forms hydrogen bonds with DNA. In order to see if these two residues are
solvent accessible in our simulation, we computed their rSA (Tables S6.5 and S6.6).
Residue R111 had a rSA of 12.7% in the most populated cluster, which can be considered
to be buried. However, this amino acid had a high rSA value in the second most populated
cluster, giving a weighted average of 20.4%. Therefore, this residue is actually solvent
accessible. Residue R133 had a weighted average rSA of 53.7% and thus is also solvent
accessible. Kucukkal and Alexov5 reported an average number of hydrogen bonds with
water of 1.68 for residue R133 and 0.47 for residue R111 in their MBD-only simulations.
We obtained an average of 2.96 for R133 and 1.59 for R111 in the last 800 ns of the
simulation. It is thus evident, that these residues are more solvent accessible when the fulllength protein is considered. Kucukkal and Alexov5 did not report the total number of salt
bridges observed in their simulations, however, they reported the loss of two salt bridges
(R133-E137 and K119-D121) upon mutation of residue R133. We computed all salt
bridges in the same manner as them, using the Salt Bridges plugin for VMD 43. A total of
499 salt bridges were identified but most of them appeared in only a small fraction of the
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frames and only 35 were stable during the last 400 ns of the simulation (Table S6.7). Most
of these salt bridges occur between the NTD and the MBD domains. Salt bridge K119D121 is only present in very few frames (Fig. S6.9A). Lys119 formed hydrogen bonds with
neighbouring residues 115-117 and Asp121 with Lys109 and Arg111. The salt bridge
R133-E137 can be observed at the beginning of the simulation but is lost in the last 400 ns
of the simulation. This is consistent with the study by Kucukkal and Alexov5 who observed
this salt bridge in their 220 ns simulation (Fig. S6.9B), but it underlines the need for
sufficiently long sampling times.

Coarse-grained simulations sample two different conformations
In order to investigate other possible folds of the protein, we ran four coarse-grained
simulations using the PLUM model25. Three different configurations were used as starting
points: A) the structure of the all-atom simulation after 800 ns, B) the initial structure built
with Modeller, and C) model “B” with its loops refined (Fig. 6.5).

Figure 6.5 Coarse-grained simulations of MeCP2 using the PLUM model25.
Simulations started from three different conformations: structure of the all-atom
simulation after 800 ns (A), the initial structure built with Modeller9 (B) and structure
“B” with refined loops (C).

154

The configuration at 800 ns in the MeCP2_1 simulation (Fig. 6.5A) was used as the starting
point for a coarse-grained simulation, henceforth referred to as CG1. Similar to the RMSD
in the all-atom simulation, the RMSD of the protein converges to 3.5 nm but continues to
fluctuate. The large RMSD value indicates that the overall topology of the structure
changed. A cluster analysis was used help to identify the differences.

Figure 6.6 RMSD from the initial structure of the protein (the MeCP2_1 model after
800 ns of simulation) in the CG1 PLUM simulation.

We clustered the conformations sampled in the entire trajectory using the method of Daura
et al.30 with a 2.0 nm cut-off. Two main conformations were revealed: 1) a single globule
and 2) two globules connected by a loop (Fig. 6.7). The first two clusters had a single
globule configuration but the third had two distinct globules connected by a loop. In this
structure, the connecting loop starts at residue 228 and ends in residue 242. A similar
conformation can be observed in the eight cluster. The minimum distance between the
amino acids of the two globules throughout the simulation shows that the two-globule
conformation was sampled at the beginning of the simulation, around 700 ns and at 2,600
ns of simulation. The first two times this conformation was sampled, the linker between
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the two globules was long enough to stabilize it for ~100 ns. In contrast, the two-globule
conformation sampled at 2,600 ns had a shorter linker and it coalesced into a single globule
after 20 ns.

Figure 6.7 Minimum distance between the two globules in the CG1 PLUM simulation.
A two-globule conformation is sampled at the beginning of the simulation at 700 ns
and once again at 2,600 ns. The single globule and two-globule conformations have
their different domains marked following the color code in Fig. 1.

Two different replicas (simulations CG2 and CG3) were run for the model built with
Modeller (Fig. 6.5B). Their RMSD converged in the first 200 ns but the simulations were
extended to 500 ns (Fig. 6.8A). Since the reference structure for the RMSD calculation is
the initial frame i.e., the unfolded structure, a high RMSD value is to be expected.
Simulation CG2 sampled conformations similar to those observed in the all-atom
MeCP2_1 simulation, albeit more compact (Fig. 6.8B). Simulation CG3 collapsed into a
globule which appears to be an energetic minimum since the system could not sample any
other conformations (Fig. 6.8A). Interestingly, the loop that remained solvent-exposed for
this entire simulation, spans residues 168 to 201 and corresponds to the ID domain (Fig.
6.1).
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Figure 6.8 (A) RMSD from the initial structure (Modeller model) of the CG2 and CG3
PLUM simulations. Brown: Most populated cluster in the entire CG3 PLUM
simulation. (B) Radius of gyration of the CG2 PLUM simulation. Blue line: The
average Rg of the MeCP2_1 system. Green: The average structure of the most
populated cluster in the MeCP2_1 simulation. Magenta: The average structure of the
second most populated cluster in the last 400 ns of the CG2 PLUM simulation.

A fourth coarse-grained simulation (CG4) started from the Modeller model with its loops
refined (Fig. 6.5C). Since the starting structure had not been energy minimized, a high
RMSD value is to be expected. This simulation sampled two-globule conformations similar
to those observed in the CG1 simulation albeit with the connecting loop located between
residues 161 and 205. Interestingly, the location of this loop matches the ID domain (Fig.
6.1). The protein underwent two main transitions during the simulation. It became more
compact during the first 40 ns, it sampled two-globule conformations from 40 to 315 ns,
and it sampled a single globule for the rest of the simulation (Fig. 6.9).
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Figure 6.9 (A) RMSD from the initial structure (Modeller model with refined loops)
and (B) minimum distance between the two globules of simulation CG4. The protein
becomes more compact and at 40 ns (red line) it starts to sample two-globule
conformations. After 270 ns (blue line) the two globules merge together and a single
globule is sampled.

A cluster analysis with the method of Daura et al.30 and a 2.5 nm cutoff of all coarsegrained trajectories concatenated found 23 different clusters (Table S6.8). The first eight
clusters contain 95.3% of all structures sampled. Four of these clusters are single globules
and four are two-globule conformations. Only the single globule conformations had
overlap between trajectories.
To further understand the conformational space sampled by all coarse-grained trajectories,
we performed a single Principal Components Analysis (PCA) on all simulations. Even
though each simulation sampled different conformations, these get closer to one another
over time, when projected onto the first two eigenvectors (Fig. 6.10). This implies that the
protein tends toward a similar, limited conformational ensemble in all four simulations.
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Figure 6.10 Principal Component Analysis. Projection of all coarse-grained
trajectories on the first two eigenvectors, each trajectory is depicted with a different
colour. Simulations CG2 and CG3 started from the same conformation. The starting
points of all simulations are marked in red and the end points in yellow.

All-atom two-globule conformations transition into a single globule
Given that the two-globule conformation had only been sampled by the coarse-grained
force field, new all-atom simulations were run starting from this conformation. Modeller 9
was used to generate the initial structures via homology modeling. Three templates were
used to generate the models: One for the first globule (NTD and MBD domains), one for
residues in the connecting loop (ID and TRD domains) and one for the second globule
(CTD domain).
Model MeCP2_2 was built using the two globules from the most populated cluster with a
two-globule conformation in the first 500 ns of simulation CG1. The first template
contained residues 1-235, the second template had an extended peptide with residues 230249, and the third one contained residues 311-486 from the second globule (Table S6.9).
The peptide used in the second template was generated using Pymol44. Using a longer
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peptide for the second template produced single-globule models, with the two globules
merged into one and a long loop forming a hoop.
In order to study whether the secondary structure in the MBD domain would have any
impact on the stability of the two-globule conformation, we generated another model using
an all-atom configuration as a template for the first globule. We used the final structure
after 400 ns of simulation as the first template for model MeCP2_3. The loop in Model
MeCP2_2 was used as the second template and the second globule (residues 311-486) from
simulation CG1 as the third template (Table S6.9).
Model MeCP2_2 collapsed into a single globule after only 20 ns of simulation and did not
sample any other conformations, therefore, we did not continue the production run beyond
60 ns. Model MeCP2_3 did not dwell into the same local minimum and its production run
was extended to 600 ns. It sampled the two-globule conformation for a longer time but
eventually the two globules melted into one, albeit with a more extended structure than the
previous model and retaining the secondary structure (Fig. 6.11). It is possible that this
conformation was not stable enough because the connecting loop was not in a water-soluble
conformation. Simulations of the connecting loop could help us shed some light on this
matter.

Figure 6.11 RMSD to the initial structure of models (A) MeCP2_2 and (B) MeCP2_3.
Green: The most populated cluster in each trajectory. Model MeCP2_2 samples two-

160

globule conformations during the first 125 ns (blue line), it then undergoes a
transition to a single globule.

Comparing all simulations
Using the PLUMED plugin45 for GROMACS13, we computed the α-helical content of the
all-atom simulations, as well as acylindricity and asphericity of all simulations.
The α-helical content was computed by generating a set of all possible six residue sections
in the protein and calculating the RMSD distance between each residue configuration and
an idealized α-helical structure. This is done by calculating the following sum of functions
of the RMSD distances,
𝑟𝑖 − 𝑑0 𝑛
𝑟0 )
𝑠=∑
,
𝑟𝑖 − 𝑑0 𝑚
𝑖 1−(
𝑟0 )
1−(

where the sum runs over all possible segments of an α-helix. This collective variable was
first defined by Pietrucci and Laio46 and all parameters were set equal to those used in their
original paper: 𝑑0 = 0.0, 𝑟0 = 0.08 nm, 𝑛 = 8 and 𝑚 = 12.
Model MeCP2_3 sampled conformations with a wider array of values for both the α-helical
content and the Rg than the MeCP2_1 simulation (Fig. 6.12). The trajectory analyzed for
this all-atom simulation does not include the 150 ns from the bigger simulation box in
which the protein underwent initial folding.
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Figure 6.12 α-helical content of the protein structure vs radius of gyration in the allatom and two-globule all-atom simulations. Comparison between the all-atom
simulation (MeCP2_1, left) that started from an extended structure and the one that
started from a two-globule conformation (MeCP2_3, right). Orange: Individual
measurements of α-helical content. Purple: Individual measurements of R g.

In 1971, Šolc showed that the shape of polymers can be quantified using the eigenvalues
(L1, L2 and L3) of the tensor of gyration47. The symmetry of a polymer, or in this case, of
a peptide, can be described by asphericity,
𝟏
𝒃 = 𝑳𝟏 − (𝑳𝟐 + 𝑳𝟑 )
𝟐
and acylindricity,
𝒄 = 𝑳𝟐 − 𝑳𝟏 .
Figure 6.13 shows the results. All simulations sampled similar values; however, the coarsegrained simulations sampled a wider array of values. From the four coarse-grained
simulations, simulation CG1 is the most akin to the all-atom simulations.
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Figure 6.13 Acylindricity and asphericity vs radius of gyration in the all-atom, coarsegrained and two-globule all-atom simulations. The coarse-grained simulations
sampled structures with lower asphericity, higher acylindricity and higher radius of
gyration than the all-atom simulations. Orange: Individual measurements of
asphericity and acylindricity. Purple: individual measurements of radius of gyration.

The ID and TRD domains are highly flexible
In order to thoroughly explore the conformations that the flexible ID and TRD domains
that form the connective loop can sample, all-atom simulations were run on the ID and
TRD domains (residues 164-310). Five replicas were run with two different force fields:
Amber99SB*-ILDNP15 (simulations A1-A5 in Table S6.1) and CHARMM36IDPSFF16
(simulations C1-C5 in Table S6.1), using the loop in model MeCP2_3 as the initial
structure.
Figure 6.14 shows Rg and end-to-end distance of all structures sampled by the ten
simulations. One of these simulations sampled very compact structures but the other nine
sampled an array of structures with end-to-end distances between from 3 nm to 23 nm, and
radius of gyration from 2.5 nm to 6.5 nm. Table S6.10 shows the most sampled
conformations in all ten simulations. Overall, the Amber force field sampled more compact
structures than the Charmm force field, in agreement with previous studies 48–50.

163

Figure 6.14 Radius of gyration vs end-to-end distance of five all-atoms simulations of
the

ID

and

TRD

domains

run

with

Amber99SB*-ILDNP

(A)

and

CHARMM36IDPSFF (B). The peptide is unstructured and can sample a large
number of conformations, from compact (low radius of gyration and end-to-end
distances) to extended structures (large end-to-end distances). Each simulation is
shown in a different color.

In order to understand the role of length in the connecting loop between globules, we
simulated the two connecting loops found in the coarse-grained simulations. Two all-atom
simulations were performed, one in which the loop spanned residues 228 to 242 (observed
in simulation CG1, see Table S6.2), and another with the loop containing residues 161 to
205 (observed in CG4, see Table S6.2). The initial structures were taken from the most
representative structure of the two-globule conformation in the corresponding coarsegrained trajectory. Modeller9 was used to add the missing side-chains and to obtain allatom structures. The shorter loop (residues 228-242) sampled conformations with the
radius of gyration lower than 1.5 nm, whereas the longer loop (residues 161-205) had
conformations with the radius of gyration of up to 2.5 nm (Fig. 6.15).
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Figure 6.15 Radius of gyration vs end-to-end distance in all-atom simulations of the
two connecting loops found in the coarse-grained simulations. A) Loop with residues
228-242. B) Loop with residues 161-205. The shorter loop sampled more compact
structures.

Comparing these two simulations with those of the entire ID and TRD domains (Fig. 6.14)
further underlines the relationship between the length of the loop and its compactness for
these particular sequences and range of lengths. The shorter loops observed between the
two globules may result in insufficient spacing to stabilize the two-globule conformations
sampled in the coarse-grained trajectories, which would explain why they eventually
merged into a single globule. Moreover, the two-globule all-atom simulations may be
unstable due to the poor initial conditions of the loop generated with Modeller. We
hypothesize that a stable two-globule conformation would feature a longer separating loop
than observed in our simulations.

Comparing the simulations with AlphaFold prediction
Last year, the field of bioinformatics had a major breakthrough when the deep learning
model AlphaFold was able to successfully predict the three-dimensional structure of
proteins from their sequence12. Since then, the model has been used to predict 98.5% of the
proteins in the human proteome51; all the structures are available to the community in a
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database hosted by the European Bioinformatics Institute (https://alphafold.ebi.ac.uk).
Nevertheless, predicting the structure of IDPs remains a challenge, as the vast number of
low and very low confidence regions from the structures predicted by AlphaFold overlap
with regions predicted to be disordered52.
The model we built with Modeller9 (MeCP2_1) has the N- and C-terminal ends extended
into the solvent, and its radius of gyration is large (8.4 nm). In contrast, the model predicted
by AlphaFold12 is much more compact (𝑅𝑔 = 4.9 nm) and with an overall spherical shape
(Fig. 6.16). The per-residue confidence score (pLDDT) of almost all residues is either low
or very low; only the MBD domain was predicted with confidence (pLDDT > 70). Since
the model had such low confidence, we used it as the initial structure for three all-atom
MD simulations (Table 6.1).

Figure 6.16 Comparison of the models generated by A) Modeller9 and B) AlphaFold12,
with their respective MBD domains aligned with each other. The model generated by
AlphaFold is much more compact than the one generated by Modeller.

Three replicas of the AlphaFold12 model were run for 400 ns each. Each simulation
sampled a different folding path and converged to a different conformation (Fig. S6.10).
Using the PLUMED plugin45 for GROMACS13, their α-helical content, acylindricity and
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asphericity were determined (Fig. S6.11). The conformations sampled by all three
AlphaFold12 simulations have similar asphericity and acylindricity values. They sampled
conformations that are more spherical and less cylindrical than the conformations sampled
by the MeCP2_1 Modeller9 simulation. Since the starting structure has a low radius of
gyration (𝑅𝑔 = 4.9 nm) we argue that it introduced a bias in the folding path towards more
compact structures. Each AlphaFold12 replica had a different α-helical content, and only
one of them sampled values to similar those observed in the Modeller 9 simulation.
The AlphaFold prediction was not stable in water and, the only exception being the MBD
domain, underwent further folding of all of its domains. Although AlphaFold does a
remarkable job predicting the presence of disorder, it cannot solve IDP structures53. These
simulations should serve as a cautionary tale on the use of predicted models for IDPs; as
explained by Strodel in her review54, extensive simulations are recommended to equilibrate
the protein and sample its conformational space.

6.5

Conclusions

In this work we have presented a multiscale study of MeCP2, comprising six all-atom and
four coarse-grained simulations of the full-length protein, as well as twelve all-atom
simulations of the ID and TRD domains. Together, they represent the first computational
attempt to study the full-length MeCP2 protein.
The initial model was built starting from the NMR structure of the MBD domain1 and
building the rest of the protein by ab initio modeling. Two main different conformations
were sampled in the coarse-grained simulations: a globular structure similar to the one
observed in the all-atom force field and a two-globule conformation. This second
conformation was not stable in the all-atom force field, probably because the length of the
connecting loop was not long enough to be water-soluble. The conformational ensemble
sampled by the 1,550 ns all-atom simulation is in good agreement with the available
experimental data1,31. Our model had 4.1% of α-helix content compared to 4% found
experimentally31. In addition, our model predicted amino acid W104 to be buried, and
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amino acids R111 and R133 to be solvent accessible, in accordance with
experiments37,41,42. Finally, we used the model predicted by AlphaFold12 to run three allatom simulations. The model was not stable in water and underwent further folding. This
model is more compact than the one predicted with Modeller 9, and consequently, it
sampled conformations more compact and spherical than those sampled in our Modeller
simulations. We recommend caution when using structures of intrinsically disordered
proteins predicted by AlphaFold.
With a total of 3 μs of atomistic simulations and 4.7 μs of coarse-grained trajectories of
full-length MeCP2 models, extensive conformational space of this protein was sampled.
Our longest atomistic simulation (MeCP2_1) converged after 800 ns to a very stable
structure. When compared to CG, it is reasonable to assume that the all-atom models are
more accurate, so the drift of the CG models towards more compact structures is likely to
be an artifact. The results show that no single method (atomistic or CG simulations, or
AlphaFold modelling) is sufficient on its own for predicting the conformational ensemble
of a large IDP such as MeCP2. Our simulations add structural and dynamical detail to the
low-resolution information previously available from experiments and could help study
disease-associated mutations in their structural context.
We finish by speculating on how the one- and two-globule conformations that were
observed in CG simulations and also transiently in MD simulations, could be investigated
experimentally – as discussed above, IDPs pose formidable challenges to both experiments
and simulations. One possible way might be high-speed atomic force microscopy (HSAFM) that has very recently been demonstrated to be able to characterize the structure and
dynamics of IDPs (polyglutamine tract binding protein-1 and four of its variants as well
as two other IDPs) by Kodera et al55. In particular, for some of their systems they reported
temporarily appearing two-globule conformations and order-disorder transition with an
associated change in the (relatively short) linking intrinsically disorder region between the
globules. Given that MeCP2 has a long and very flexible disordered region spanning the
ID and TRD domains, it is tempting to speculate that fluctuations between the one- and
two-globule conformation might be directly detectable or/and inducible in HS-AFM. This
seems feasible since force spectroscopy56 and MD simulations57 have shown that for

168

intrinsically disordered regions forces in the range of a few tens of pN may cause
significant stretching and that the free energy barriers are very low. In HS-AFM, the forces
are higher up to about 100 pN and there is frictional interaction, albeit very small, with the
substrate55,58. Thus, the two-globule state that was only marginally stable in current
simulations might also be observable in HS-AFM. Such experiments would potentially
also allow investigation of the properties of the linker and the globules.

6.6

Supplemental information

Figure S6.1 Alignment of ten of the rejected models of the full-length MeCP2 protein
built with Modeller18.
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Table S6.1 Details of all-atom simulations.
System

MeCP2_1

Water

Na/Cl

Counterions

Duration

Starting

molecules

each

(Cl)

(ns)

structure

793,027

2,205

37

150

Built with
Modeller

MeCP2_1 resized

119,575

337

37

1000

MeCP2_1

MeCP2_2

113,980

324

37

60

Built with
Modeller

MeCP2_3

458,344

1,277

37

60

Built with
Modeller

MeCP2_3 resized

119,989

339

37

600

MeCP2_3

Loop Amber

324,046

0

31

10

loop in
MeCP2_3

Loop A1 resized

71,863

0

31

100

Loop Amber

Loop A2 resized

44,741

0

31

100

Loop Amber

Loop A3 resized

224,502

0

31

100

Loop Amber

Loop A4 resized

129,396

0

31

100

Loop Amber

Loop A5 resized

131,425

0

31

100

Loop Amber

Loop Charmm

324,046

0

31

10

loop in
MeCP2_3

Loop C1 resized

186,560

0

31

100

Loop
Charmm
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Loop C2 resized

281,911

0

31

100

Loop
Charmm

Loop C3 resized

54,506

0

31

100

Loop
Charmm

Loop C4 resized

293,861

0

31

100

Loop
Charmm

Loop C5 resized

102,059

0

31

100

Loop
Charmm

Loop 228-242

4,665

0

0

100

Loop in twoglobule, CG1

Loop 161-205

13,658

0

12

100

Loop in twoglobule, CG4

AlphaFold R1

144,569

411

37

400

AlphaFold
model

AlphaFold R2

144,569

411

37

400

AlphaFold
model

AlphaFold R3

144,569

411

37

400

AlphaFold
model

Table S6.2 Details of coarse-grained simulations. These were run using the PLUM
model with implicit water.
System

Duration (ns)

CG1

3,000
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CG2

500

CG3

500

CG4

700

Figure S6.2 RMSD of the TRD domain in the all-atom full-length protein simulation.

Table S6.3 Secondary structure content in the last 400 ns of the all-atom MeCP2_1
simulation clustered with a 0.5 nm cutoff and the Daura et al. method39.
Cluster #

# frames

α-helix

β-strand/turn

coil/bend

1

23,559

22

121

333

2

11,556

16

99

353

3

2,920

26

110

338

4

1,189

15

112

342

172

5

499

31

109

327

6

137

8

120

340

7

58

14

109

343

8

58

21

109

338

9

19

23

101

345

10

3

15

115

343

11

3

22

91

350

Total/Average

40,001

20

113

339

Percentage

coil
bend
turn
strand
heli
bridge

2
2

2

Residue number

Figure S6.3 Percentage of frames in the last 400 ns of the NTD domain with every
type of secondary structure.
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Percentage

coil
bend
turn
strand
heli
bridge

2
2

2

Residue number

Figure S6.4 Percentage of frames in the last 400 ns of the ID domain with every type
of secondary structure.

Percentage

coil
bend
turn
strand
heli
bridge

2
2

2

22

22

2

2

2

2

2

2

2

2

2

2

2

2

2

2

Residue number

Figure S6.5 Percentage of frames in the last 400 ns of the TRD domain with every
type of secondary structure.

Percentage

coil
bend
turn
strand
heli
bridge

2
2

2

Residue number

Figure S6.6 Percentage of frames in the last 400 ns of the CTDα domain with every
type of secondary structure.
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coil
bend
turn

Percentage

strand
heli
bridge

2
2

Residue number

coil
bend
turn

Percentage

strand
heli
bridge

2
2

Residue number

Figure S6.7 Percentage of frames in the last 400 ns of the CTDβ domain with every
type of secondary structure.

Figure S6.8 Principal Component Analysis. Projection of the MeCP2_1 simulation on
the first two eigenvectors, coloured by time. (A) Projection of the entire protein. (B)
Projection of the TRD domain. The protein samples the largest portion of this 2Dspace during the first 600 ns of the simulation. In contrast, the TRD domain begins to
sample more conformational space in the second half of the simulation.
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Table S6.4 Relative solvent accessible surface area (rSA) of residue W104 in the four
most populated clusters of the all-atom simulation.
Cluster #

weight

rASA

1

23,559

7.4

2

11,556

9.6

3

2,920

6.6

4

1,189

11.4

Weighted average:

8.1

Table S6.5 Relative solvent accessible surface area (rSA) of residue R111 in the four
most populated clusters of the all-atom simulation.
Cluster #

weight

rASA

1

23,559

12.7

2

11,556

37.4

3

2,920

5.8

4

1,189

44.3

Weighted average:

20.4
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Table S6.6 Relative solvent accessible surface area (rSA) of residue R133 in the four
most populated clusters of the all-atom simulation.
Cluster #

weight

rASA

1

23,559

50.3

2

11,556

56.7

3

2,920

65.5

4

1,189

63.0

Weighted average:

53.7

Table S6.7 Salt bridges in the last 400 ns of the full-length all-atom MeCP2_1
simulation.
Interacting

Protein domains

residues
Glu11 – Lys27

NTD – NTD

Asp15 – Arg162

NTD – MBD

Asp17 – Lys135

NTD – MBD

Lys22 – Glu214

NTD – TRD

Glu55 – Lys109

NTD – MBD

Glu55 – Arg111

NTD – MBD

Glu55 – Arg133

NTD – MBD

Glu66 – Arg91

NTD – MBD
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Glu66 – Arg85

NTD – MBD

Glu76 – Arg85

NTD – MBD

Asp97 – Lys171

MBD – ID

Arg111 – Asp121

MBD – MBD

Asp154 – Arg167

MBD – ID

Asp156 – Arg167

MBD – ID

Arg168 – Glu205

ID – ID

Glu235 – Lys254

TRD – TRD

Glu235 – Lys347

TRD – CTDα

Arg253 – Glu315

TRD – CTDα

Arg253 – Glu365

TRD – CTDβ

Arg255 – Glu258

TRD – TRD

Asp260 – Lys337

TRD – CTDα

Lys266 – Glu282

TRD – TRD

Arg270 – Glu394

TRD – CTDβ

Lys271 – Glu404

TRD – CTDβ

Glu290 – Lys307

TRD – TRD

Arg294 – Glu318

TRD – CTDα

Glu298 – Lys307

TRD – TRD
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Lys304 – Asp407

TRD – CTDβ

Lys321 – Glu397

CTDα – CTDβ

Arg344 – Glu365

CTDα – CTDβ

Arg420 – Glu473

CTDβ – CTDβ

Glu432 – Arg453

CTDβ – CTDβ

Arg453 – Glu457

CTDβ – CTDβ

Glu455 – Arg458

CTDβ – CTDβ

Glu457 – Arg471

CTDβ – CTDβ

Figure S6.9 Salt bridge interaction between residues Lys 119 and Asp 121 (A) and
between residues Arg 133 and Glu 137 (B).
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Table S6.8 Clusters sampled in the coarse-grained simulations. The first eight clusters
contain 95.3% of the sampled structures.
Cluster #

# Structures

Sampled in

1

22,293

CG1, CG2, CG4

2

5,810

CG1, CG2, CG3,
CG4

3

4,986

CG1

4

3,492

CG1, CG3

5

3,027

CG1, CG4

Representative structure
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6

2,768

CG4

7

1,257

CG4

8

1,165

CG1

Table S6.9 Templates used to generate models MeCP2_2 and MeCP2_3. The blue
templates were taken from the coarse-grained simulation CG1, the green template
was generated with Pymol52, the red template was taken from an all-atom simulation
of the NTD+MBD domains66 and the purple template was taken from model
MeCP2_2.
Template 1

MeCP2_
2

Template 2

Template 3

Final Model

181

MeCP2_
3

Table S6.10 Conformations sampled by the ID+TRD domains simulations. The five
most populated clusters are shown for each simulation.

Figure S6.10 RMSD of the three AlphaFold simulations. Right: Alignment of the most
sampled structure from 200 to 300 ns (light colours) and the most sampled structure
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in the last 100 ns (dark colours) of each replica. Both structures are very similar to
each other in the three simulations, ratifying the convergence of the simulations.

Figure S6.11 Prediction of protein disorder for MeCP2. Residues beyond the red
threshold line are predicted to be disordered. The different domains are marked
following the color code in Fig 1.

Figure S6.12 Autocorrelation of the radius of gyration of MeCP2_1. Red: exponential
fit 𝒚 = 𝒂 ∙ 𝒆−𝒃𝒕 with 𝒂 = 𝟏. 𝟎𝟑𝟎𝟐𝟕 and 𝒃 = 𝟏𝟎. 𝟑𝟒 ns.
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Figure S6.13 Distribution of structures sampled in the MeCP2_1 simulation.
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Conclusions and future directions

7

7.1
7.1.1

Conclusions
Conclusions

Using a computational approach, we characterized the structure and dynamics of two
biologically relevant proteins: a globular protein and an IDP. This work illustrates the
challenges faced when dealing with an IDPs, as well as the importance of having long
simulations. The primary conclusions of this thesis are presented below.

7.1.2

All-atom MD simulations can be enough to provide insight into
globular proteins

Most of the structures of globular proteins have been solved, either by experimental
methods or by homology modeling with high confidence in the prediction1. This makes, in
principle, performing all-atom MD simulations very straightforward. Furthermore, often
there is no lack of experimental data to which to compare the results obtained in silico. The
challenge lies in that oftentimes there is so much information already available, that one
has to be creative in order to provide new insights, standard analyses are not enough.
Chapter 4 showed how state-of-the-art techniques such as residue interaction network
analysis can be successfully applied to explain the mechanisms that give rise to different
behaviours in two highly similar homologous enzymes. It also underlines the need for long
simulations. As the results showed, some of the previously reported results from shorter
trajectories were transient and no longer observed after the first microsecond of simulation.

7.1.3

MD simulations can be a complimentary technique to
experimental procedures

High-speed atomic force microscopy (HS-AFM) is one of the few techniques that can be
used to evaluate the structure and dynamics of intrinsically disordered proteins2. An
important question that arises when using this technique is whether the molecular
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behaviour observed in the protein under study is affected by the tip-sample and surfacesample interactions. It has been shown that the transferred energy from the AFM tip to
sample is partitioned amongst all degrees of freedom of the molecule, so that the transferred
energy per degree of freedom is negligibly small; importantly, it dissipates quickly, over a
time much shorter than 1 μs3. However, there is no direct way to assess the impact of
surface-sample interaction. By performing MD simulations of the MBD domain of MeCP2
in solution and in the presence of a surface, we were able to show that the surface-sample
interaction did not affect the secondary structure of the protein, validating the experimental
results. The surface used in the simulation had the same surface charge density as the
surface in the experimental setup.

7.1.4

MD simulations can provide new insights when it’s difficult to
obtain experimental data

The structural characterization of a large IDP such as MeCP2 is a challenge. Indeed, our
results show that no single method is sufficient on its own for predicting the conformational
ensemble of MeCP2. A combination of all-atom and coarse-grained simulations, as well as
backmapping to atomic structures, and extensive simulation times were needed.
Thankfully, we do have some structural information against which we could validate our
models. The all-atom model MeCP2_1 was in good agreement with all available
experimental data, and the coarse-grained simulations sampled a structure similar to those
observed in HS-AFM experiments. Our simulations help to put together a more complete
picture where experiments had only looked at individual features and they provide
predictions for new experiments.

7.2

Future directions

We studied two native TIM enzymes (TcTIM and TbTIM) as well as a chimeric protein in
chapter 4. We examined their electrostatic interactions and found some significant
differences in the hydrogen bonds of the three proteins. This led us to hypothesize that the
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thermal stability of the chimeric protein is higher than TbTIM but lower than TcTIM,
which would need to be validated by experiments.
In chapter 6, we characterized the structure and dynamics of the full-length MeCP2 protein.
Our results can be the basis of further studies such as studying disease-associated mutations
in their structural context or its interactions with its biological partners.
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